The use of adjuvants in the production of Rh antisera in animals by Shatin, Harriet Sommer,
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Dissertations and Theses (pre-1964)
1949
The use of adjuvants in the
production of Rh antisera in
animals
https://hdl.handle.net/2144/17471
Boston University


Boston University
Graduate School
Dissertation
The Use of Adjuvants in the Production of Rh Antisera
in Animals
*>y
Harriet Sommer Shatin
/ / /
(B.A., Brooklyn College, 1939; M.A., University of Penn-
sylvania, 1940)
Submitted in partial fulfillment of
the requirements for the degree of
Doctor of Philosophy
1949
Digitized by the Internet Archive
' in 2016
'
https://archive.org/details/useofadjuvantsinOOshat
\c
\ 44
5
First Reader
Second Reader
Approved
by
_ _
Professor of Bacteriology ano^Fxperimental
Pathology
Associate Professor of 3

aTOPICAL OUTLINE
Page
INTRODUCTION
The Problem
1. Need for Rh-Hr antisera-use in the diagnosis of Rh
types of individuals 1
a. Transfusions 2
(1) Immunization
(2) Reaction after previous transfusions
b. Pregnancies 3
c. Typing of infants 3,4
d. Medico-legal problems 4
e. Genetical studies of familial groups 4
f. Anthropology 4
2 History
a. Discovery of the Rh antigens 4,5,6
b. Lines of investigation
(1) Nomenclature 6,7
(2) Rh-Kr antigens 6-20
(a) Inheritance of the Rh-Hr antigens 7
(1) Wiener’s theory of multiple
allelomorphs 7,8
(2) Fisher’s theory of three closely
linked pairs of genes 8
(b) Kinds
(1) Rhesus antigens 9,10
--
’
'
&
*
*
..
- El iBf
Enolsjrlenjairf Bi/o±vft*<? ".-SSI* no.UoBafS
r
'
' i!«—•—- ~ •»»••• ^ *• “*
o > V-.-OVOO'
—
-
'
.
. .
—
bPace
(2) Human antigens 10-15
(a) D (d) C (g) c
(b) Du (e) Cw (h) cv
(c) d (f) Cu (i) E
(j) e
(c) Location of Rh-Hr antigens 16-18
(d) Chemical studies on the Rh-Hr antigens -- 18-20
Rh antisera 20-
(a) Sources
(1) Human 20-27
(a) Conditions producing Rh
antibodies 20-24
1
.
Pregnancy
2. Incompatible transfusion
3. Hyperimmunization
4. Voluntary active
immunization
5. Influence of heterospecific
immunization
(b) Transmission of fetal cells
into the mother 24
1. Wiener’s theory
2. Levine's theory
(c) Genetic predisposition toward
antibody production 25
1. Haldane's gene-permeability
of placenta
2 Levine ' s theory - general
genetic expression
“ - - - - — -
. i
'
r
0 , ;
— -
.
°
.
'
•
-
.
U)
.
.
.
.
.
...
•
.
r
:
- -
-
-
;
r
-
n ‘ a;:o^qxe-. n id e r .
c3. Wiener’s "K" gene
Page
(d) Preparation of Rh antisera 25-26
1. Sources of potent sera
2. Specifications
3. Elimination of normal
iso-aggluti nins
4. Concentration of anti-
bodies
(e) Advantages and disadvantages
of human Rh antiserum 26,27
Animal
(a) Rhesus erythrocytes as antigen 28-35
1. Lands teiner and "Wiener -
rabbits and guinea pigs — 28,29
2 o Davidson and Toharsky -
guinea pigs and rabbits -- 29,30
3. Fisk and Foord - guinea
pigs 30-32
4. Gallagher and Jones -
guinea pigs and rabbits — 32,33
5. MeIvor and Lucia - guinea
pigs 33
6 • Ecker, MacFarlane and
Laipply - guinea pigs 33,34
7. Homburger - guinea pigs
and rabbits 34
8 6 Scherer - rabbits 34,35
(b) Human erythrocytes as antigen - 35-37
1. Levine and Stetson -
rabbits 35
2. Levine and Polayes - guinea
pigs and rabbits 35
-.
«
-*
.
.
-
-
—
I.
-
*
,
— - -
--- -
.
--
r.o
'
•
OCi
.
%
—
- •
-
- t
_
/ -J
_ *
— -
dPage
3, Gallagher and Jones -
guinea pigs 36
•
4. Carter - guinea pigs 36,37
(c) Human stroma as antigen 37
Gallagher and Pillischer -
guinea pigs
(d) Extracts from human erythrocyt es
as antigen 37,38
Carter - guinea pigs and rabbits
(e) Advantages and disadvantages
of animal antisera 38
(b) Types of Rh antibodies 38-40
(1) Agglutinins 39
(2) Blocking antibodies 39,40
(3) "Cryptagglutinoids”
antibodies
or
M develooing”
1 40
Technical Methods 40
(1) Agglutinins 40,41
(a) Landsteiner and Wiener
(b) Modifications - Wiener
(2) Blocking antibodies 41
(a) Inhibition of indirect blocking
test
1. Wiener 41
2. Race 41,42
3. Diamond and Abe Is on 42,43
(3) Slide tests
(a) Diamond and Abels on’s 43,44
.. _
0
.
. -
’
!
;v. .
1 ad;;
—
_ ,
— -
: ;
*
..
• a
—
r * ‘ )
-
il: o I ‘ *i 1 u' jfrl
!J> .
i:v.j
x:
oi rtw
1
ePage
(b ) Simmons’ 44
(4) Use of various colloidal media
instead of saline
(a) Adult serum or plasma 44-46
(b) Serum of premature and newborn
infants 46
1. Lubinski 46
2. Levine 46
3. Gurevitch, Polish.uk and
Hermoni 46,47
4. Witebsky, Rubin and Blum - 47-50
(c) Albumin - Diamond and Denton - 50
(d) Cerebrospinal fluid - Jacobowicz
and Bryce 51
(e) Gelatin - Diamond and Denton — 52,53
(f) Glue - Wheeler and Scholl
(5) Coombs test - "developing” test 53-55
(a) Direct test 53
(b) Indirect test 54
1. Method of testing
2. Preparation of rabbit anti-
human-globulin serum
3. Fractions of human serum as
antigens
4. Information as to the mature
of "incomplete" antibodies
a. Serological basis
b. Chemical basis
\ k t *
—
— -
— .1
—
-
<
'.o;
; •
- t
- (o)
I
-
<
' 0
' • -
-
><?, : 0
.
- i
:
• c
'
-
.
.
.
'
-
zl i3cf Ibo eriO
fPage
5* Effect of rabbit anti-
globulin sera to species
other than man
(6) Elution of antibody from sensitized
cells 57
(a) Agglutinins 57,58
1, Habsrman and Hill
2. Carter and Loughrey
5. Wheeler and Scholl
(b) Blocking antibodies - Wheeler
and Scholl 58
(7) Capillary tube methods 58,59
(a) Chown 58
(b) Berlin 58
(c) Krieger and Bryce 58
(8) Hemolytic activity of agglutinins
and blocking antibodies In vitro -- 59
(d) Nature of Rh antibodies 59-67
(1) Chemical nature 59-61
*
(a) Chemical studies 59,60
(b) Serological studies 60
(c) Electrophoretic studies 61
(d) Electric charges 61
(e) Molecular weight 61
(f) Ultracentrifugal studies 61
(2) Physical characteristics 62,63
(a) Effect of heat 62
„ _ _ . „ _ _
'
1 r
.
- -
-
-
.
\ f .
;
*
'• ' of f ,r\
.
i irf fi 'tori' ' 0*1X o oil
e • o r>
"
"u oal
{>)
—
-
' /
'
)
c«
Page
(b) Effect of pressure 62
(c) Effect of photo-oxidation 62,63
(d) Effect of merthiolate 63
(e) Effect of saline 63
(f) Effect of various colloidal
media 63
(3) Immunological characteristics - 63,64
(a) Species in which found 63
(b) Time of appearance 64
(c) Persistence of antibodies 64,65
(4) Serological characteristics 64,65
(a) Rapidity of reaction with
red cells 64,65
(b) Reversibility of attachment
to red cells 65
(c) Strength of clumping 65
(d) Specificity of clumps 65
(e) Reaction with cells in the
presence of complement 65
(5) Clinical characteristics 66
(a) Permeability of placenta — 66
(b) Importance in the production
of erythroblastosis fetalis 66
(6) Evidence for a third order anti-
body 66,67
(e) Concentration of antibodies 68
(f) Specificity of Rh antibodies 68,69
T f ).
<
— ( )
r o { )
*
-
r
’
•
r
")
( }
—
/
.
>
l
'o)
r 1 CoieS ( )
( )
/ . \
t \
. /
—
'»)
- _
-
-
' o'
—
r f \
\ ‘ /
_
r
:
-
' v
hPage
FRESEOT INVESTIGATION
1 .
2 .
Rationale
a. Present status of the Rh antisera - summary
b. Use of adjuvants in immunization procedures
(1) Purposes
(2) Examples
(3) Application of the adjuvant method of immuniza-
tion to the present problem
Experimental
Experiment I Macacus rhesus erythrocytes as the antigen
Experiment II Human Rh positive erythrocytes as the
antigen
(1) Selection of animals
(2) Preparation of antigens
(3) Preparation of emulsions
(4) Injection schedule
(5) Bleeding schedule
(6) Testing of sera
(a) For agglutinins
(b) For blocking antibodies
(c) For specific antibodies
(7) Criteria for adequate and weak antibodies
70-72
70
70,71
70.71
71
71.72
72-74
74-79
74
74.75
75
75
75.76
76-79
76.77
77.78
78.79
79
3* Results
Experiment I
Experiment II
(1) Agglutinins
79
80-32
80-32
-r 1
-- *
'
- i
-
;
>'
- _
- -
—
.
/
t-r
-
r
•
~o- lircs erld sb b
-
ii e. B9sJ ’OCT-rlt ; o svli 'zo- ri>: «£ •
•
/•
_
_
. ri
J 1 - f .\ - ‘t
.
- * _ _ -
— •;
. —
f '
V '* )
:
i)
-inli
(•)
( )
( :
QV
si r s
:.I crie
f r j
.
Page
i
(2) Blocking antibodies 82
(3) Coombs antibodies 82
DISCUSSION 83-87
SUMMARY 38-89

LIST OP TABLES
TABLE I - Rh-Hr Antigens and Antibodies
TABLE II - The 36 Possible Rh Genotypes, Showing the
Reaction of Each with Each of the Six Antisera
TABLE III - Experiment I Material Injected per Animal
TABLE IV - Experiment II Groups of Guinea pigs Used
TABLE V - Experiment II Material Injected per Anima.l
TABLE VI - Experiment II Distribution of Adequate and
Suggestive Rh Antisera
TABLE VII - Experiment II Summary of Strength of Rh
Agglutinin Reactions of Guinea Pigs’ Antisera
-I
,
-
"
'
.
1INTRODUCTION
The Problem
77
Since the discovery of the Rh antigens 9 years ago,
and subsequent discovery of the Hr antigens, 85 evidence in-
dicating the importance of these antigens has been accumula-
ting rapidly, Rh-Hr typing is important in clinical medicine,
in medico-legal situations, in the genetical study of familial
groups, and in anthropology.
The need for supplies of Rh antisera has taken its place
next to that for anti-A and anti-B blood grouping sera. The
latter problem has been pretty well solved by the use of serum
from human volunteers of groups A and B whose anti-B and anti-
A agglutinins have been stimulated to increased strength and
1 fiO
avidity by the injection of A and B group substances, A
number of workers have attempted to supply the needed anti-
Rh sera by centralized collection and distribution of potent
sera from Rh-sensitized women, particularly mothers of erythro-
blastotic infants. Nevertheless, the supply, particularly that
of the subtypes, is far from adequate, is sometimes variable,
and the sera are expensive. It is obvious that methods of pro-
ducing a constant source of Rh antisera in quantity would be
of great importance. The present investigation summarizes the
results of an intensive study of possible methods of producing
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such sera in animals
Clinically, the importance of the Rh-Hr antigens lies
in their antigenicity for humans. The production of the in-
dividual antibodies depends on two factors: the potency of
the antigen, and the reactivity of the individual to the anti
gen. It is customary to define an Rh negative person as one
145in whom the Rh0 (D) antigen is missing. The 3 clinical
situations where it is necessary to know the Rh type arise
in transfusions, pregnancy, and in infants with evidence of
erythroblastosis
•
Rh negative males or females may be immunized by pri-
mary transfusions 4 *^*^ >63,84,102,132 so that any
further injections of Rh positive blood would cause a trans-
fusions reaction. Although more than 1 transfusion of Rh
positive blood is usually needed to initiate antibody forma-
tion, there is wide individual variation. Sensitization may
be produced by only 1 transfusion.- Transfusion reactions
have also been produced in response to the other Rh and Hr
antigens.’"* 4 * 44(4 * 4 ‘^ gn these cases it is advisable to sub-
type the cells of the recipient, and those of the donor to
*
*
pick out compatible blood for subsequent transfusions. Also,
Rh negative males and females may have been transfused with
Rh positive blood in the past, in which case the use of an

Rh positive blood may cause an immediate transfusion reac-
tion,85
In pregnancies sensitization of females to the Rh
antigens by transfusions may cause hemolytic disease of the
first born.91 * 94 Erythroblastosis fetalis is most frequent-
ly caused by Rh incompatibility between mother and infant.
The role of the Rh factor is highly significant. Only 15
per cent of the women in the general population are Rh nega-
*
tive, whereas among mothers of erythroblastotic infants, 90
per cent are Rh negative #83 ,89 Wallerstein105 stated that
D is responsible for 92 per cent of the cases. The rest
result from iso-immunization against the A and B group sub-
stances, 188 Hr factors, 98 or Rh subgroups. In most instan-
ces the first infant is not affected. However, if the mother
has been transfused previously with Incompatible blood, she
may never be able to produce a normal infant. The prognosis
for future pregnancies of women with erythroblastotic in-
•
fants may be made by determining the Rh type of the father. 31
If he is heterozygous for the antigen against which she has
produced antibodies, there is a 50-50 chance that a subse-
quent pregnancy will be normal, but if he is homozygous there
is little chance.
If an infant shows evidence of erythroblastosis, anemia
,-
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4or jaundice, it is necessary to type the infant’s blood
prior to transfusion. Generally Rh negative blood is pre-
ferred, but it is also necessary to type the infant’s blood
in case the sensitization is due to one of the Rh subtypes
or the Hr antigens.
In addition to its clinical importance, Rh typing is,
useful in medico-legal problems 1 "-" 7 > 100 and in familial100 *
113,115,128,141,144 ^ .. . . _ 10 .9 9 9 9 and anthropological studies.
History
In 1923 Ottenberg107 and in 1938 Darrow27 suggested that
the clinical condition of erythroblastosis fetalis was caused
by an antigen-antibody reaction in the bloodstream of the
fetus. Landsteiner, Levine and Janes 70 in 1928, and Neter100
in 1936 described the appearance of intragroup atypical agglu-
tinins several weeks after transfusions. In 1939 Levine and
oy
Stetson reported the occurrence of an isoagglutinin in a
female who had given birth to a macerated stillborn fetus,
and had experienced a transfusion reaction when transfused
for the first time with blood from her husband of the same
group. Their explanation of the patient’s reaction to her
first transfusion was that the blood and/or tissues of the
fetus contained antigens inherited from the father that were
not present in the mother, and that isoimmunization resulted
1 •
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5from transplacental transfer of fetal red cells and/or tis-
sue cells into the maternal circulation*
In 1940 three papers appeared which pointed to the dis-
covery of a new antigen present in human erythrocytes. Land-
steiner and Weiner77 reported the finding of an agglutinin
in the serum of rabbits that had been immunized with cells
from rhesus monkeys. After they had removed agglutinins re-
acting nonspecifically with human cells and those reacting
with the agglutinogen M, an agglutinin remained which re-
acted independently of A and B, M and N, and P, with 39 of
45 human bloods. Wiener and Peters-1-33 observed 3 patients in
whom transfusions with blood of the homologous group resul-
ted in hemolytic reactions. In 2 of the patients the aggluti-
nins were found to be identical with each other, and to cor-
respond with Landsteiner and Wiener’s anti-rhesus aggluti-
nin. Eighty-five per cent of the white population was found
to be Rh positive. In reviev/ing intra-group transfusion re-
actions, Wiener and Peters noted that every recorded instance
of reaction to the first transfusion occurred with intra- or
postpartum patients. Their observation supported Levine a.nd
Stetson’s hypothesis that iso-immunization is brought about
during pregnancy. Finally, Levine and Katzin reported 7
transfusion cases in which both wife and husband were of the
same blood group, but where atypical maternal antibodies acted
-*
-
#
~
-
.
.
.
~
_
*
_
*
.
'
t
6 •
on the cells of the husband. No history of previous blood
transfusion was found in any of the cases. The agglutinins
of 1 serum were found to correspond to the Rh agglutinins
of Landsteiner and Wiener’s rabbit antiserum. Additional
evidence for the relationship of miscarriages, stillbirths,
and erythroblastosis fetalis to iso-immunization during
OQ
pregnancy was presented by Levine, Katzin and Burnham^ in
87
1940, and by Levine and Polayes in 1941.
Thus, the demonstration of the new antigen, Rh, was the
result of the linking of 3 lines of investigations. The
first was the study of intra-group transfusion reactions in
individuals who had received multiple transfusions. The
second was the investigation of intra-group transfusion re-
actions in females not previously transfused, and associated
with disease of the fetus. The third was the production of
an agglutinin in animals immunized with the erythrocytes of
the rhesus monkey. Agglutinins produced under all 3 condi-
tions were found to be identical.
Rh-Hr Antigens
Nomenclature .- Before entering into a discussion of the
Rh-Hr antigens and their antibodies, it is necessary to iden-
tify the Rh-Hr antigens. In discussing the genes, antigens,
and antibodies, two systems of nomenclature are in use. One

is the Weiner system154 using Rh and Hr designations. The
other is the Race-Fisher system114 * 118 *
119 based on the let-
ters C, D, and E. Castle, Wintrobe and Snyder14 recommended
that Weiner's terminology be used followed by the Race-Fisher
terms in parentheses. Since this is very cumbersome the ter-
minology which most clearly depicts the situation will be
used in the present paper. As indicated in Table I there
are 3 Rh antigens and 3 Hr antigens, with their corresponding
antibodies. This simplification does not take into account
the variants of the antigens, which are discussed below.
Inheritance Familial studies have disclosed that the
presence of the Rh-Hr antigens in the red cells is genetical-
ly determined. Ho antigen is present in the blood of a child
that is not present in the blood of its parents. As with the
MN antigens in man, genes determining presence of the Rh and
Hr antigens are of equal dominance. In other words, if an
individual is heterozygous for C, his red cells contain both
C and c antigens. These cells will react with both anti-C
*
and anti-c sera. The presence of C will not mask that of c,
nor will the reverse situation occur. The same holds true
for the other two pairs of antigens. D-d and E-e.
There are two main theories concerning the inheritance
of the Rh-Hr antigens. Wiener’s theory146 of multiple allelo

TABLE I
t
Rh-Hr Antigens and Antibodies
Antigen Antibody
Rh ^4 Wiener Race-Fisher Wiener Race-Fisher
antigens
and their rh* C * anti-rh *
present
anti-C
orig
r
antibodies
Rh° D anti-Rh0 anti-D A
rh” E anti-rh” anti-e H
Rh nega-
tive anti- Hr* c anti -Hr * anti-c "V
gens and
their Hr° d anti-Hr0 anti-d
antibodies
Hr' e anti -Hr” anti-e
"v~\

morphs postulates 8 allelomorphic genes, each of which de-
termines 1 of the 8 possible combinations of Rh antigens
that can be present in human red cells. Since one gene is
inherited from each parent, 2 of these 8 genes are present
in an individual. The possible allelomorphs are: r,r’,r”
,
R°,Rl,R2 ,r^,Rz . Fisher’s theory-1- ^ is that the Rh type
of an individual depends on a series of 3 closely linked
pairs of genes, C-c, D-d, and E-e. Each gene determines the
inheritance of 1 antigen. Since 1 gene of each of the 3
pairs is transmitted from each parent, an individual may be
homo- or heterozygous for each pair of antigens. That is,
he may inherit CC, Cc, or cc, DD, Dd, or dd, and EE, Ee, or
ee. The genotypes, phenotypes, and their serological re-
actions are given in Table II.
The substantiation of one theory or the other hinges
upon the question of whether independent segregation of the
3 genes occurs. If independent segregation of the 3 genes
were demonstrated, then Fisher’s theory would be substantia-
ted. If, however, this were shown not to occur, then Wiener’
theory would not be contradicted. For example, if CDe x cde
parents could produce a cDe offspring, this would lend cre-
dence to Fisher’s theory. However, if the 3 antigens in the
parent were always found to be inherited as a unit in the
offspring, Wiener’s theory would remain uncontested. To date
.<
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TABLE II
The 56 Possible Rh Genotypes, Showing the Reaction of Each
With Each of the Six
* w
-
*
Antisera
Genotype Reaction with serum
anti-C anti-D anti-E anti-c anti-d anti-e
cde/cde
"
•A -A — — —
CDE/CDe A -A •A — ~A
CDE/Cde
-A -A, -A — ~A A
CDE/CdE “/•
-A -A — A-
CDE/cDE A -A -A
A
—
-
CDE/cdE A -A -A A -A —
CDE/cDe
-A “A -A A- A
CDE/cde
-A -A -A A ~A A
CDe/CDe
-A •A mmmm A
CDe/Cde
-A -A — -A A
CDe/CdE
-A -A -A — -A -A
CDe/cDE
-A
-A -A - -A
CDe/cdE
-A -A -A A A- A
CDe/cDe
~A -A -A
CDe/cde
-A -A — A -A A
Cde/Cde
-A -- mmmm -A -A
Cde/CdE
-A — -
A
— A A
Cde/cDE
-A ~A -A -A A A
Cde/cdE
-A
-A 7- -A -A
Cde/cDe
-A -A A A
Cde/cde
-A — A A
CdE/CdE
-A —
-A -A
CdE/cDE
-A -A -A -A A
CdE/cdE
-A A A A
CdE/cDe
-A -A - -/- A -/
CdE/cde
-A A A A A
cDE/cDE A -A -A
cDE/cdE —
-A -A -A -A
cDE/cDe —
-A A A
-A
cDE/cde —
-A A A A- A
cdE/cdE «... - - A -A -A
cdE/cDe —
-A -A A -A -A
cdE/cde — A A A A
cDe/cDe — A -/•
-A
cDe/cde —
-A — A A A
cde/cde — — — A- A- -A
The symbols C, D, E, etc., are explained in the text.
The symbol / is used to separate the two chromosome formulas
(Fishers ) ss=genes (Wiener).

9no proof negating Wiener’s theory of multiple Rh-Hr alle^o-
128
morphs has appeared. Familial studies have so far shown
that the genes of a parent are inherited as a unit by the
offspring. The present tendency is to accept Wiener ’ s . the-
ory of the mechanism of inheritance of the Rh-Hr genes.
Rhesus Antigens .- When first discovered, the Rh anti-
gen was thought to be a single substance common to both the
erythrocytes of the Macacus rhesus and those of Rh positive
individuals.78 Since then, the rhesus antigen has been
found to be similar to the most antigenic of the Rh substan-
ces, D. There are indications that the rhesus antigen and
human D are not identical. The investigations of Landsteiner
and Wiener78 and of Davidson and Tobarsky28 demonstrated that
there were differences in specificity of antisera produced
in response to rhesus and human erythrocytes. Since the
varieties of Rh and Hr antigens were not known at the time,
no conclusions can be drawn as to the relationship of the
rhesus Rh antigen and the human factor, D. Fisk and Foord^-*-
found that Rh antisera produced in guinea pigs in response
to rhesus erythrocytes would differentiate among Rh -/ and
Rh negative adults, but strongly clumps all infants' red
cells. This observation was confirmed by Strattoni28 Whether
lack of specificity was caused by the source of the antigen
or by the source of the antisera has not been indicated. No

10 .
studies have been published in which animal anti-human-Rh
erythrocyte sera have been tested against infants’ cells*
Types of Human Rh-Hr Antigens .- The existence of the
various Rh-Hr antigens has been demonstrated by the immune
responses of individuals who have received red cells con-
taining incompatible Rh factors either by transfusion or,
in pregnant women, by passage of antigens of the fetal cells
into the maternal circulation. The existence of these anti-
gens has also been demonstrated by the reactions of red cells
of the individual with known Rh-Er antisera.
The first Rh antibodies were found by Landsteiner and
Wiener'^ in rabbits immunized against rhesus red cells.
These antibodies were compared by Wiener and Peters-^8 with
antibodies from 2 individuals transfused with blood known to
be of the same group, but who showed transfusion reactions.
The rabbit and human antibodies were found to give parallel
results when tested against the red cells of various indi-
viduals. On further investigation the red cells of 85 per
cent of the white population were found to be agglutinated
by these antibodies. This antigen is now designated RhQ (D).
Clinically, an Rh positive person has the Rh (D) antigen,
the most potent immunizing antigen of the Rh-Hr series, in
120
his red cells. It accounts for approximately 98 per cent
tyo
of human sera containing Rh antibodies. Both agglutinins ,

11
81,126
and blocking antibodies 34 * 126 to this antigen have
been demonstrated. Anti-B antibodies have been produced in
response to transfusions, to stimulation by fetal red cells,
and to artificial immunization. This antigen has slight
dosage effect. That is to say, there is little difference
in strength of reaction with anti-D serum between the cells
of homozygous individuals, DD, and those of heterozygous in-
dividuals, Dd.
Stratton429 discovered a second allelomorph for the gene
D by testing the cells of an individual CDe/cde with a number
of strong anti-D sera. These cells gave variable reactions
with the different sera. With some they agglutinated stron-
gly, with some weakly, and with some no reaction was observed.
This suggested the presence of another allel for the gene D.
The former antigenic expression was weaker than that of the
D gene. The Du sera of Stratton were mixtures of anti-D and
anti-Du . No pure anti-Du sera could be produced by absorp-
tion of the mixture with cells containing the D antigen.
When Stratton, by injecting the cells CDue/cde, attempted
to immunize two Rh negative individuals (one showing a mix-
ture of anti-D and anti-Du antibodies in his sera, the other
none) there was no production of anti-Du nor increase in
titer of the same. However, anti-Du was produced in an arti-
ficially immunized male inadvertently. In Van Loghem’s 9 ^
t
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attempt to produce a pure anti-E antibody, cells supposedly
of cdE specificity were used. However, in testing for anti-
bodies, both anti-D and anti-E were observed. On retesting
the donor’s cells, the latter were found to be of cDuE. As
suggested by Stratton this case indicated that typing with
pure anti-D serum put a cDE individual into a cdE category.
Whether there is any dosage effect could not be determined,
for no individual who was homozygous for Du was available.
Small d, the Hr antithetical allelomorph of the antigen
D, was obtained by Diamond^-® and by Hill and Haberman.^ The
latter reported 2 antisera produced by iso-immunization of
mothers. Both sera contained anti-d agglutinins with anti-c
blocking antibodies. Whether Diamond’s anti-d'-’’7 was pure
was not reported.
There are 5 allels for the C locus. The first anti-
C serum was reported by Levine, Burnham, Katzin and Vogel®^>86
in 1941. Three human sera were tested against a series of
unselected bloods. One gave a 73 per cent incidence of ag-
glutination. In the light of current knowledge it was a pure
anti-C antibody. In t he same year Wiener-^S reported a ”70n
per cent serum. Since then, there have been numerous in-
stances of anti-C antibodies appearing in the sera of people
transfused with incompatible blood and in those of iso-immu-
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nized gravid females. Most anti-C sera are mixtures of anti-
C and antl-D. If the antl-D antibodies are blocking anti-
bodies, and if the anti-C are agglutinins, such sera may be
used to type cells suspended in saline. If both are agglu-
tinins, anti-D blocking antibodies can be added. These pre-
vent the action of anti-D agglutinins, and the sera then can
be used against cells in saline. The most desirable sera
contain only anti-C antibodies. Van Loghem97 attempted to
produce a pure anti-C by immunization of a male volunteer.
Such antibodies were obtained; agglutinins were present to
a titer of 1:32, blocking antibodies to a titer of 1:128.
However, anti-Du antibodies were also produced. The C anti-
gen has little dosage effect.
The second allel, Cw
,
is antigenic in blood transfusions,
RO
and produces hemolytic disease of the newborn. Race, Mou-
rant and Callender-1-'1-6 found that about one half their anti-C
sera actually contained a mixture of anti-C and anti-Cw
,
thus
apparently explaining the discrepancies found in the behavior
of different anti-C sera. Only blocking antibodies have been
found, no agglutinins. There is a very definite dosage ef-
fect. The cells of homozygous individuals react more stron-
gly than those of heterozygous individuals. As indicated by
Race1 -1-9 the genetic relationship between C and Cw is clear,
but not the antigenic relationship. C can stimulate the pro-

duction of both anti-C and anti-Cw . Naturally occurring mix-
tures of antl-C and anti-Cw cannot be split by absorbing with
C or Cw cells. An artificial mixture made by adding pure
anti-C to pure anti-Cw can be split by absorption. IJnlike C,
Cw has a strong dosage effect. The cells of a homozygous in-
dividual were clumped much more strongly by pure anti-Cw than
those of a heterozygous person.
Evidence for the third allel}^®Cu
,
is still incomplete.
The antithetical antigen, c, is the most antigenic of
the Hr series. An antiserum was observed by Levine^ which
agglutinated all Rh negative cells and many Rh positive cells
Since it had an inverse relationship to the Rh antigen, he
termed it Hr. Shortly afterwards Race and Taylor-*- 2^ obtained
a more potent antiserum of the same specificity. Further re-
ports of such antisera have been made, and antl-c antibodies
have been produced in response to transfusions and transpla-
cental iso-immunization. Since the cells of homozygous in-
dividuals react much more strongly than heterozygous, there
is a dosage effect.
Evidence of a fifth allel, cv
,
has been suggested by
Race, Sanger and Lawler^^but proof is lacking. According
to the authors, cv bridges the gap between C and c. When
anti-C-7^cv serum is absorbed by either cv c or Cc cells, all
-•
.
*
-
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agglutinins are removed. The use of the term c was indi-
cated by 2 factors. One was that the cells gave a double
dose effect with anti-c sera. The second was that cv seg-
regated with genes D and E. CDE is a rare chromosome in
England, cDE a common one.
The Rh antigen E was discovered by Wiener- in 1943.
This antiserum only reacted with 30 per cent of the popula-
tion. Race and Taylor*1**1*'1* obtained such antisera from 2 Rh
positive (having antigen D) mothers in the same year. Anti-
70
E sera, particularly in the pure form, are rare. Dick00 re-
ported a pure anti-E agglutinin in an Rh negative woman.
Rice and Watson-1-20 found a pure anti-E antibody in an Rh
positive woman. Pure anti-E agglutinins, followed by the
appearance of blocking antibodies, were produced in an Rh
negative male volunteer by Van Loghem# There is little
or no dosage effect.*1**1*6
The antithetical gene e is rarely antigenic. The first
y
1 03
anti-e was found by Mourant x in an Rh positive patient,
CDE/cDE, who had received numerous transfusions. A strong
dosage effect was noted. Cells from a homozygous individual
reacted more strongly than those of a heterozygous indivi-
dual to the anti-E serum«

16
Location of Rh-Hr Antigens .- Saliva has been investi-
gated for its content of Rh antigen using the inhibition
technic with known anti-Rh sera and known Rh positive red
cells. Levine and Katzin88 and Wiener and Forer140 were
unsuccessful but Boorman and Dodd8 and Mohn and Witebsky"*"8^
demonstrated Rh antigen in saliva. Of the 14 samples from
Rh negative people, none inhibited the 2 anti-Rh sera tested.
Of the 51 samples from Rh positive people, 27 showed slight
inhibition and 24 showed none. Mohn and Witebsky examined
30 samples of saliva. In 2 or 3 instances, they had the im-
pression that small amounts of Rh substances were present.
Their conclusions were that the appearance of Rh substances
in saliva could not be determined with certainty. If present,
they were in such low concentrations as to make their demon-
stration difficult because of the viscosity of the saliva.
Boorman and Dodd consider that the almost complete insolubi-
lity of these antigens in water is the probable explanation
of the above finding.
Gastric juice has been tested for the presence of Rh
antigens by Mohn and Witebsky, who found Rh antigens in
12 of the 20 samples from Rh positive persons and none in
2 from Rh negative individuals. Seven of the 12 samples
showed relatively large amounts of Rh substances. Rh sub-
stances in gastric juices may be specific, but the majority
~,
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of the positive gastric juices inhibited agglutination of
both Rh^ and Rhg cells.
Seminal fluid and sperm cells, when examined by Levine
and Katzin®® were not found to contain Rh substances.
Amniotic fluid contains Rh substances as indicated by
the investigation of Witebsky and Mohn^6^and Mohn and Witeb-
* /
sky.^"*" Of 100 samples of amniotic fluid, 71 of 86 samples
from Rh positive and none from 14 Rh negative infants v/ere
positive. Thus, among Rh positive infants about 4 out of 5
are secretors. The presence of Rh substances in the amnio-
tic fluid is dependent on the infant’s not the mother’s blood
group. The secretion of Rh substances into amniotic fluid
seems to be independent of the secretion of group specific
substances. There were some instances of Rh]_ and Rh
.2 sub-
stances, but most of the positive amniotic fluids reacted
with both Rh^ and Rhg cells. Three Rh positive erythroblas-
totic infants were non-secretors . Mohn and Witebsky found
that more definite differentiation between secretors and non-
secretors could be obtained by purification and concentration
of the amniotic fluid. This was accomplished by dialysis
* * *
of the fluid, removal of precipitate, lyophilization, and
resolution of the dried material in l/lO the original vol-
ume of saline
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Various tissues have been examined for Rh antigens by
Boorman and Dodd. 5 Most of the analyses were made on liver,
kidney, and spleen, and in some cases on heart, suprarenals
,
pancreas, brain, and salivary glands. Aqueous suspensions
of ground-up tissues and aqueous extracts of tissues were
tested by the inhibition technic. Aqueous extracts of tis-
sues were entirely negative, but tissue suspensions were
positive. They found that the Rh substances in tissues are
relatively insoluble in water but very soluble in alcohol,
and that there is considerably more Rh substance in the body
tissues than in the body fluids. These findings have yet
to be confirmed by other workers.
*
Chemistry of Rh-Hr Antigens .- Using physical methods,
Belkin and Wiener'*' were able to concentrate Rh antigens 8 to
32 times, as determined by the inhibition technic. Their
method was to combine Sharpies centrifugation with running
the material through the Travis colloid mill. The end pro-
duct consisted of uniform minute particles.
Calvin et al-*-2 obtained stroma by Sharpies centrifuga-
tion of hemolyzed human erythrocytes. In testing Rh posi-
tive and Rh negative stroma for specificity by the inspec-
tion method, they found that only stroma from Rh positive
cells gave inhibition. The stroma were also tested for
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their sensitivity to heat under varying atmospheric condi-
tions. If exposed to 56 C for 5 minutes in saline, inhibi-
ting ability of the stroma was destroyed. If exposed to
the same temperature for the same length of time, but in
air or vacuum without moisture, there was no decrease in
inhibitory activity.
These authors were able to separate the stroma into
2 fractions by adjusting the pH. One fraction, called elinin,
inhibited Rh antisera. The other, stromatin, had no inhibi-
tory power. Elinin contained 40-50 per cent alcohol jether
extractable lipids; stroma contained 20 per cent. The Rh
substance in the ether soluble fraction is more stable to
heat than the Rh substance in stroma, resisting 56 C for one
hour. When the ether-soluble substance is recombined with
protein, the material is thermolabile again.
1 PCarter, by extracting human erythrocytes with alcohol
and ether, obtained a lipid Rh inhibitor substance which she
called the Rh hapten. It is essentially the same as that
described by Calvin et al. Two methods for assaying the Rh
substance were used. One tested the ability of the substance
to fix complement in the presence of potent Rh antisera.
The second tested its capacity to inhibit potent Rh antisera.
That this lipid substance is a hapten is indicated by
its non-antigenicity when injected into 96 guinea pigs. How-
.•
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ever, when it was combined with a protein carrier, in this
instance egg albumen, 5 of 24 inoculated guinea pigs pro-
duced antibodies to group 0, Rh positive human red cells.
Since no further information was given concerning the num-
ber of Rh positive cell suspensions tested or reactions with
Rh negative red cells, it is not possible to determine whether
Rh antibodies actually were produced.
*
In both immunized guinea pigs and iso-immunized humans,
the in vivo neutralization of Rh antibodies was demonstrated
by the fall in antibody titer after injection of the lipid.
Rh Antisera
Human . - There are 5 main methods of actively immunizing
humans against the Rh-Hr antigens. (1) The unavoidable res-
ponse of reactive gravid females to the red cells of the
fetus which are Incompatible for the Rh-Hr factor. (2) The
inadvertent transfusion of an individual with such incompa-
tible red cells. (3) The hyperimmunization of iso-immunized
individuals. (4) The active immunization of human volunteers.
(5) Heterospecific immunization along with specific immuni-
zation of volunteers.
Since 1939 numerous instances of Rh sensitization may
be found in the literature. Both agglutinins and blocking
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antibodies have been observed. Such human antisera have
provided the material for most of the studies on Rh anti-
gens and antibodies.
Hill, Haberman and Orozco64 injected 2 mothers of ery-
throblastotic infants intravenously with small doses of Rh
positive cells. In 1 woman injections were started 6 days
after delivery. At that time only blocking antibodies with
a titer of 1:4 were present. The titer of agglutinins after
immunization was 1:2,048, that of blocking antibodies 1:8.
The response was probably a combination of the usual post-
partum rise of Rh antibodies and immunization. The second
case showed a postpartum titer of 1:2,048. Eighteen months
later the titer had fallen to 1:64. After hyperimmunizati on
the titer had mounted to 1:2,560 by the twelfth day.
Diamond, Wiener and van Loghem have actively immunized
male volunteers. Diamond was able to immunize 16 of 35
men. He gave them an initial intravenous injection of 50-
500 ml of blood followed by 0.05 to 0.3 ml of blood 3 times
a week for 3 weeks. Wiener and Sonn-Gordon, who immunized
9 men by 2 injections of 2 ml of blood 4 months apart, ob-
tained antibody production in 2 but in lower titers than
those obtained by Diamond. Male volunteers were then injec-
ted with small amounts of Rh-j_ and Rh2 red cells at 6-week
.:
.
intervals over the period of a year. Five of 6 persons pro-
duced useful Rh antisera. Wiener observed that when Rh2
blood was injected, anti-D agglutinins were the first to
appear, then anti-D blocking antibodies, and finally anti-
E agglutinins. When Rh^ cells were used, the observations
were similar. Anti-C were the last antibodies produced.
97 98
Of 17 men immunized by Van Loghem, * who used frequent
intravenous injections of small amounts of blood (Cde and
cdE), 4 produced Rh antibodies. Two produced anti-C sera
in response to Cde cells. In 1 the titer of the serum in
saline was 1:8 and 1:16 in albumin, and that of the other
was 1:32 in saline and 1:512 in albumin. Another produced
low titers of anti-D, 1:2 in saline and 1:4 in albumin. The
anti-E serum contained antibodies that would react only in
albumin to a titer of 1:64. One of 3 nuns injected by Van
Loghem with Cw antigen produced a pure Cw blocking antibody
with a titer of 1:8 after 20 injections.
Van Loghem observed 2 particularly interesting facts.
One was a fall in titer of the anti-E blocking antibody
despite continued injections of the antigen and no response
on hetero-immunization. This would indicate that an over-
dose of the Rh antigen is possible in artificial immuniza-
tion of humans. The second observation was the exclusive
finding of blocking antibodies without the appearance of
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agglutinins in 1 person* In the other 3 antisera, agglu-
tinins were followed by blocking antibodies.
The influence of hetero-immunization on the production
Oft
of Rh antibodies was studied by Van Loghem ^ on 14 male
volunteers who had previously received from 15 to 42 in-
jections of Rh antigen without producing Rh antibodies ac-
tive in either saline or albumin. Three of the 14 produced
Rh antibodies after injections of triplovaccine (TAB) and
tetravaccine (TABC ) along with injections of the Rh antigen.
It is interesting that the 3 showed clinical signs of sick-
ness and rise of temperature in response to the vaccineo
The observation that heterospecific Immunization sti-
mulated the production of Rh antibodies is important* Wie-
ner^4 ^ ^as suggested the use of heterospecific immunization
with typhoid vaccine to lower the Rh antibody production in
gravid females on the assumption that a more potent antigen
such as typhoid vaccine would compete with the weak Rh anti-
96gens at the sites of antibody production. Levine stated
that such injections might well stimulate further response
rather than act as a diversion. The experiment of Van
Loghem corroborates this point. However, the data of Van
Loghem on the effect of hetero-immunization would have been
more convincing if the Coombs test had also been carried out
with the sera of the group that showed no antibodies by other
.-
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technics
•
Transmission of fetal cells into the mother .- Wiener-1- 53
considers that leakage of fetal red cells into the maternal
circulation rarely occurs in the course of pregnancy, but
at the time of labor and at parturition, when there is dis-
turbance of the placenta. This is suggested by the fact
that congenital hemolytic disease rarely occurs with the
first-born unless there is a history of previous transfusion.
96Levine believes that iso-immunization is probably
initiated toward the latter half of pregnancy when the blood
vessels in the villi gradually approach the maternal sinuses
and are in intimate contact over a large surface. The facts
that support Levine T s theory are: A single injection of Rh
positive cells into an Rh negative individual rarely causes
demonstrable antibody production. The degree of sensitivity
in transfused individuals rarely approaches that of Rh nega-
tive mothers of erythroblastotic infants unless multiple
transfusions are given. This would indicate that the Rh
negative mother has had the optimal opportunity for immuni-
zation, which is continuous exposure to the antigen over a
long period of time. Another fact that points to a continu-
ous antigenic stimulus is the increase in antibody titer that
is observed during pregnancies following the sensitizing preg-
nancy.
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Genetic predisposition toward antibody production • -Hal-
dane60 has postulated that a gene exists in man determining
placental permeability to formed elements* However, if we
assume that minute quantities of fetal blood pass the pla-
cental barrier, as Levine’s theory indicates, this must
occur in every pregnancy*
Wiener**- 53 has explained the varying responses to the
Rh antigens on the basis of a particular gene which he calls
K. A homozygous individual who carries KK will be very sus-
ceptible and produce a large number of antibodies in res-
ponse to a mild stimulation* The individual who is homo-
zygous for kk will not react at all to Rh antigens by anti-
body production. The heterozygous individual Kk will pro-
duce Rh antibodies if strongly stimulated. There is no
factual basis for this gene.
Levine92 has suggested that individuals vary in their
ability to produce Rh antibodies and that this ability is
a general expression of the person’s genetic constitution*
Preparation of anti-Rh sera *- The antibodies used for
typing red cells for the Rh factor are primarily agglutinins.
When unavailable, blocking antibodies are used* As indica-
ted above, the main sources of Rh antibodies are from sensi-
tized pregnant women and transfused males and females. In-
creasing use is being made of volunteers. Additional sources
*
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of antibodies were made available by the absorption of bloc-
king antibodies and by concentration of sera too weak for
use in their original form. According to the standards of
the National Institute of Health-*-33 an Rh antiserum must
have a minimal titer of 1:32 units. If diluted, the protein
content must not be reduced below 25 per cent of normal.
The normal anti-A and anti-B iso-agglutinins must be
removed before human sera are specific for Rh. This proce-
dure is accomplished either by absorption of sera of indi-
viduals of Group A, B, and 0 (individuals of Group AB con-
tain no iso-agglutinins in their sera) with Group A and B
Rh negative red cells or by the addition of group specific
substances A and B. The A substance is derived from the
gastric mucosa of hogs, AB substances from the gastric muco-
sa of horses.-1-34 The latter method is preferable since there
is no nonspecific decrease in titer of the Rh antibodies.
It is necessary to check anti-Rh sera periodically for loss
of titer and specificity. Cappell ard McFarlane-*- 3 found
that anti-Rh sera may develop weak anti-A and anti-B iso-
agglutinins on standing.
Advantages and Disadvantages of Human Anti-Rh Sera .-
One of the most important advantages of human Rh-Hr antisera
is their specificity. So far no other animal has been able
to produce antisera to the Rh subtypes or to variations with-
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in those subtypes. Good human anti-Rh sera are more potent
than the best animal antisera. This advantage makes the Rh
typing of red cells more accurate. With human Rh antisera
it is possible to differentiate Rh positive from Rh nega-
tive infants, whereas the animal anti-rhesus sera aggluti-
nate all infants* cells strongly.
On the other hand there are certain disadvantages.
Many human Rh antisera contain more than 1 antibody, and the
presence of blocking antibodies may mask the action of the
agglutinins if both are of the same specificity. Many human
Rh antisera contain antibodies to more than 1 antigen. If
these mixtures contain 1 antibody in the form of agglutinins
and another in the form of blocking antibodies, the latter
may be absorbed out, but the presence of 2 separate agglu-
tinins is a more difficult situation to deal with. The
source of Rh antisera is not constant, for the titer of
donors is maintained for a variable length of time. Ex-
cept for anti-D sera, good Rh antisera cannot be produced
in large quantities or at will.
Animal .- Since the original discovery of an anti-Rh
agglutinin in anti-rhesus rabbit *3 serum by Landsteiner and
77Wiener in 1940, numerous workers have tried to produce
anti-Rh sera in animals with varying success. All of the

published work has been done with guinea pigs and rabbits,
horses 6 and goats 7 being immunized without success. Most
workers have used erythrocytes from Macacus rhesus as the
antigenic stimulus, some have employed human Group 0, MN
Rh positive erythrocytes, one worker human stroma, and
another a lipid extract from human Rh positive erythrocytes
When Landsteiner and Wiener were unsuccessful in ob-
taining a similar agglutinin by the injection of more rab-
bits with rhesus red cells, they were able to produce Rh
agglutinins by intraabdominal injection into an unspecified
number of guinea pigs. 73 The sera was rendered specific
for Rh either by diluting to a point where it would not
give any reaction with human Rh negative red blood cells
but would clearly agglutinate Rh positive cells, or by ab-
sorbing the sera diluted 1:4 with saline with sufficient
human Rh negative red cells to remove the reaction with the
Rh negative cells. Landsteiner and Wiener defined a diag-
nostic serum as one which, when serially diluted by halves,
and tested against known positive and negative erythrocytes
showed negative reactions in 3 or more successive dilutions
with the negative cells, and positive reactions in those
dilutions with the positive cells. Using this criterion,
these authors found that one or more of 10 guinea pigs pro-
duced diagnostic sera. They checked sera from different
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sources to see how they compared. Forty-two bloods were
tested with the original rabbit's serum and with human sera
from post-transfusion cases. Parallel reactions were ob-
tained. The sera of 3 guinea pigs were checked with 110
* y
random bloods with similar results. Likewise, 159 bloods
gave parallel reactions when tested with a guinea pig anti-
rhesus serum and a human serum from the mother of a child
with erythroblastosis. There were 3 cases of discrepancies
and 3 that gave doubtful reactions with the guinea pig's
serum.
79
In 1942 Landsteiner and Wiener modified their method
for immunizing guinea pigs against rhesus erythrocytes.
The longer immunization gave a higher proportion of usable
serum and made it imperative to use the absorption technic
to eliminate agglutinins other than anti-Rh.
28Davidson and Toharsky inoculated guinea pigs intra-
qbdominally with washed rhesus erythrocytes. The guinea
pigs' sera were used on the basis of differential titration
*
between Rh positive and Rh negative cells, no attempt being
made to absorb out nonspecific agglutinins. Of the 12 gui-
nea pigs injected, 5 produced agglutinins that could differ-
entiate between Rh positive and Rh negative red cells, but
only 1 was strong enough to be used diagnostically. Of the
*„
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11 rabbits injected none produced diagnostically usable
antisera. There was some slight difference in titer between
reactions with Rh positive and Rh negative bloods. The
titers with Rh positive cells ranged from 1:3,500 to 1:7,000
and those with Rh negative cells 1:1,500 to 1:3,500# Ab-
sorption with Rh negative cells in an attempt to remove the
agglutinins for the Rh negative cells, inhibition with Witeb-
sky's A and B substances-*-® 0 and with A and B saliva-*--0 all
failed to produce a usable Rh antiserum# Comparative tests
performed on 61 human bloods with 1 guinea pig and 3 human
Rh antisera revealed 50 parallel results and 11 showed dis-
crepancies# When 25 human bloods were tested with 2 rabbit’s
antisera and 3 human antisera, 18 were in agreement and 7
showed differences#
41Fisk and Foord also produced Rh agglutinins by in-
jecting guinea pigs with rhesus red cells# The preparation
/ /
and injection schedule of the antigen, bleeding schedule,
and tests for agglutinins were similar to those used by Land-
no
steiner and Wiener# They found that absorbing the serum
diluted 1:10 with l/2 volume of Rh negative Eed cells gave
more definite differentiation between Rh positive and Rh
negative cells# The number of animals injected was not
given, but the authors stated that the sera varied consider-
ably in suitability, had weak antibody production, and failed
to distinguish between Rh positive and Rh negative bloods.
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Of 927 white adults chosen at random 15 per cent were Rh
negative and 85 per cent Rh positive, in agreement with
the observations of Landsteiner and Wiener. Using 4
potent human sera from mothers with erythroblastotic
infants random samples of adult bloods revealed similar
proportions of Rh positive and Rh negative bloods. Simul-
taneous tests with guinea pigs’ anti-rhesus sera and 2
human anti-Rh sera gave the following results: In testing
197 bloods with 1 human serum and guinea pig’s serum, 192
gave parallel results and 5 were positive with the human
antiserum and negative with the guinea pig’s antiserum.
With a second human serum, 79 of 85 bloods gave parallel
reactions and 4 showed discrepancies.
All of 312 cord bloods of infants gave strongly posi-
tive reactions with the guinea pig’s anti-Rh serum. Tests
with human anti-Rh sera differentiated Rh positive and Rh
negative infant cells. Blood collected from 9 infants 10
days after birth gave results similar to those with cord
bloods
.
Two years later Fisk and Foord^ in comparing the sen-
sitivity of guinea pig’s anti-Rh serum with those obtained
from 8 mothers of erythroblastotic infants, found that 4 of
the human sera gave parallel reactions to the guinea pigs'
antisera and 4 gave fewer positive reactions. One of the
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human antisera was found to react with only 70 per cent of
the series of adult blood samples. Absorption with Rh nega-
tive cells was used again, for this method resulted in better
differentiation of Rh positive and Rh negative cells.
In 1943 Gallagher and Jones 54 injected guinea pigs and
rabbits with rhesus red cells. The preparation of the anti-
gen and the injection schedule for the guinea pigs were simi-
78
lar to the methods of Lands teiner and Wiener® Bleedings
were taken 1 and 2 weeks after the last injection. To ab-
sorb nonspecific agglutinins, 1 volume of serum was diluted
with 4 volumes of salines and 1 volume of Rh negative cells
was added. In some cases 2 and 3 absorptions were necessary.
If the initial antibody content was low, absorption would
remove all activity. Half the guinea pigs showed agglutinins
that distinguished between Rh positive and Rh negative cells,
and about 1 out of 5 produced diagnostic serum. No Rh anti-
bodies were obtained from immunization of rabbits. The anti-
rhesus guinea pigs 1 sera were compared with 2 sera from
mothers with erythroblastotic infants. Of 156 bloods tested
with the guinea pig’s serum 83 per cent gave positive reac-
tions, Of 118 bloods tested with 1 of the human sera 85 per
cent gave positive reactions. When the anti-rhesus and the
above human sera were tested simultaneously with a second
human serum, the first two gave parallel reactions, whereas
--
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the second human serum only reacted with 54 per cent of the
bloods
.
Mclvor and Lucia-* 0^ tested 4 different injection sche-
dules immunizing guinea pigs with rhesus erythrocytes. The
absorption technic was used to produce specific Rh antisera.
Sera giving clear cut Rh positive and Rh negative sediments
were called diagnostically usable. The results were: 3 of
the 18 animals given the first injection schedule produced
usable sera; of the 5 guinea pigs on the second schedule 2
produced high titered sera and 1 fair; of the 7 survivors
on schedule 3, 3 produced high titered sera; 5 of the 9
animals on schedule 4 produced good sera.
Ecker, MacParlane and Laipplv40 injected an unspecified
number of guinea pigs with rhesus erythrocytes, some being
injected according to Landsteiner and Wiener’s78 procedure
and some subcutaneously. Sera from 2 animals were pooled,
inactivated at 56 C for 30 minutes, and absorbed with Group
A and Group B Rh negative cells (details were not reported).
Human cells were called Rh positive or Rh negative on the
basis of differential titrations. The criteria for differ-
entiating Rh positive from Rh negative cells were not clear.
Of 125 bloods of known types tested with guinea pig’s anti-
rhesus serum, 19 or 15 per cent were Rh negative. Rh agglu-
tinins were completely removed from guinea pig’s antiserum
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by absorption with human Rh positive red cells#
Guinea pigs and rabbits were injected with rhesus red
cells by Homburger,® 7 who studied inhibition of production
of Rh antibodies. The experimental group was injected v/ith
sodium salicylate to depress antibody formation. When the
sera were collected, and whether or not they were made speci-
fic for Rh antibodies was not indicated. The sera of guinea
pigs were examined for agglutinins using Lands teiner and
Wiener’s78 method and the sera of rabbits were tested by
Diamond's method53 using human albumin. Of 40 guinea pigs
originally injected, 31 survived. Of 20 rabbits, 8 survived.
In reporting the results both rabbits and guinea pigs were
combined. Twenty-one animals were in the control group. Of
these 15 showed anti-Rh agglutinins (the criteria for defi-
ning Rh agglutinins were not reported). The authors stated
that the rabbit's antibodies were stronger. However, dif-
ferent methods of testing were used. Of the 18 animals re-
ceiving sodium salicylate only 2 showed anti-Rh agglutinins.
122Scherer injected rabbits with rhesus red cells in
an attempt to inhibit the production of Rh antibodies. As
inhibiting agents, he tested ethylene disulfonate, sodium
salicylate, pyrabenzamine
,
and A and B blood group substances.
There was little difference in antibody production when tes-
ted against red cells suspended in saline and against red

cells suspended in Group AB serum. If the agglutinins were
Rh agglutinins (this cannot he determined from the paper
since no Rh negative cell suspensions and only one Rh posi-
tive cell suspension were used) such findings would indicate
that only agglutinins and no blocking antibodies were present
None of the substances tested inhibited agglutinin produc-
tion, (If these were Rh agglutinins, and Homburger’s anti-
bodies also were Rh agglutinins, these observations would
contradict Homburger 6^ ) • Another procedure which leaves
the nature of agglutinins in doubt was the use of a one-step
absorption employing 1 part serum and 5 parts of packed cells
The Rh agglutinins are quite delicate, and one would think
that such a procedure would absorb out any Rh agglutinins
nonspecifically,
A few experiments have been carried out in animals using
human Rh positive erythrocytes as the antigen. In 1939 Le-
vine and Stetson8^ injected human cells that could be agglu-
tinated by human atypical agglutinins into rabbits in an
attempt to reproduce the antibodies in animals. After ab-
sorption with human Rh negative cells, no agglutinins re-
mained, Again in 1941 Levine and Polayes gave 4 guinea pigs
and 4 rabbits a series of injections with Group 0, MN, Rh
positive red cells. No Rh agglutinins were found.
**
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Gallagher and Jones 55 published a note in 1943. Guinea
pigs were inoculated with Group 0, MN, Hh positive red cells
over a 3-month period. One or 2 weeks after the last injec-
tion of antigen, the animals were hied and the sera absorbed
with Group 0, MN, Rh negative cells using the method des-
cribed in their paper on rhesus cells as antigen. They sta-
ted that such sera distinguished sharply between known Rh
positive and Rh negative cells of all groups. No further
data were given. No indication was given as to how these
sera would react with infants’ cells.
In 1945 Carter14 injected 6 guinea pigs with human
Group 0, MN, Rh positive erythrocytes. According to the
author sera previously absorbed with Rh negative cells showed
a clear cut reaction with positive, and no reaction with nega
tive cells. Simultaneous tests were performed on 500 bloods
with standard anti-D typing serum and guinea pig’s serum,
with parallel results.
In a later report on a substance which inhibits anti-Rh
16
sera, 24 guinea pigs were injected with a 10 per cent sus-
pension of Group 0, MN, Rh positive cells intraabdominally.
The author stated that each control animal produced aggluti-
nins to human Group 0 Rh positive cells up to titers of 1:160
and above. No mention was made of a method for making these
sera specific for the Rh antibodies, nor of any reactions
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with Rh negative cells*
Gallagher and Pillischer used stroma prepared from
human Rh positive cells as the antigen* With absorbed sera
it was possible to distinguish between Rh positive and Rh
negative red cells. No mention was made of the number of
animals involved, the number producing good anti-Rh agglu-
tinins, the actual injection schedule, nor the criteria
that a good anti-Rh serum would have to meet.
Erythrocytic Extracts .- Carter in 1947 published a
preliminary report on a substance which inhibited anti-Rh
human serum. The preparation of the material is given in
the section on chemical studies under Rh antigens. Hone
of the 24 guinea pigs and 2 rabbits produced antibodies to
human red blood cells. When equal volumes of 10 per cent
lipid suspensions in 50 per cent alcohol and 10 per cent
egg albumen in saline was injected intraabdominally into
another series of guinea pigs, 5 of 24 developed agglutinins
for Group 0, Rh positive red cells. The author gave no data
dealing with removal of nonspecific agglutinins, if any,
or indicating the reactions of the antisera with Group 0,
Rh negative red cells*
17In a later paper they stated that the injection of
this material into guinea pigs which had anti-Rh antibodies
**
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in their blood stream caused a reduction in titer of those
antibodies
•
Advantages and Disadvantages of Animal Rh Anti sera .
-
The main advantage is the ability to produce sera at will.
Since animals, as far as is known, produce only agglutinins
not blocking antibodies, agglutinins would not be masked.
Vifith careful determination of the specific Rh antigens and
the absorption of nonspecific agglutinins, it might be
possible to produce "pure 1 ’ Rh antisera of the subtypEs.
There are several disadvantages to the use of animal
sera. Approximately one half of the animals injected wi th
Rh antigens do not produce Rh agglutinins. Only animal anti
sera with the specificity of anti-D have been observed so
far. No animal antisera against the other 2 Rh antigens, or
to the 3 Hr antigens, have been noted. Anti-rhesus anti-
sera strongly agglutinate all infants 1 cells and only differ
entiate between Rh positive and Rh negative adult cells.
The cells of infants have never been tested against anti-
human-red-cell antisera of animals.
Types of Antibodies .- The presence of Rh antibodies is
evidenced by their activity when brought into contact with
their specific antigens under specified environmental condi-
tions. There are two known categories of Rh antibodies.
-.
n
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agglutinins and blocking antibod5.es, and a third, (postu-
lated kind of antibody), " cryptagglutinoids" or "developing”
ant ibodies
•
3G
Rh agglutinins are specifically modified gamm globulins *
that are found in the serum of immunized humans and ani-
15 58 137
mals, attached to the red cells of sensitized infants, 9 9
and present in the milk of postpartum women who have agglu-
1 1 5Q
tinins in their plasma." > The Rh agglutinins coat the
Rh positive red cells and cause them to agglutinate when
suspended in saline or in various colloidal solutions. Ti-
trations of these agglutinins can be made in saline or in
the various colloidal solutions. Other terms used to denote
Rh agglutinins are: Wiener 1 s "bivalent" Diamond’s "thermo-
labile" or "early" or "immature" antibody, ^3 Coomb’s "com-
plete" antibody.^ 3
Rh blocking antibodies are specifically modified beta
globulins36 found in the serum of immunized humans and atta-
1 ^7
ched to the red cells of sensitized infants. Whether they
are present in the breast milk of women with blocking anti-
bodies in their plasma has not been investigated. There is
no evidence for their presence in animal Rh antisera. These
antibodies coat the red cells and saturate the Rh combining
sites of the cells.66 They produce no agglutination in the
presence of saline, but cause clumping when the cells are
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suspended In colloidal solutions. Their attachment to the
red cells when suspended in saline is shown by further addi-
143
tion of known Rh agglutinins to the test cells. The In-
hibition of agglutination indicates that the antigenic sites
on the red cell have been blocked. A more delicate test
consists of adding an anti-antibody, e.g., rabbit anti-human.
23
serum antibody, to the sensitized cells. Clumping will
occur if the blocking antibodies are present. If in the
test a colloidal solution, such as serum
,
146 plasma
,
151
albumin
,
53 gelatin
,
45 gl\ie
,
55
>
92 and others, is substituted
for saline, blocking antibodies will cause direct clumping
of the red cells.
Other terms used to denote Rh blocking antibodies are:
Wiener's 151 "univalent" or"glutinins" Diamond's 55 "thermo-
stable", "late", or "mature". Coomb's 25 "incomplete" anti-
body.
"Developing" antibodies or " cryptagglutinoids" or third
order antibody are the terms suggested by Hill, Haberman and
Jones66 for a postulated third order antibody. This antibody
coats Rh positive red cells suspended in saline, but does
not saturate the sites of antigen on the red cell. They are
only demonstrated by the Coomb's or "developing" test.
Technical Methods .-The original test for the presence
of Rh antibodies was the demonstration of agglutination.
• ?
1
.
Various modifications have been made in the technic of Land-
steiner and Wiener, the most important being the incubation
of the tests at 37 C and the introduction of gentle centri-
152fuging before reading.
Numerous workers found puzzling results when testing
for the causes of intra-group transfusion reactions and of
cases of erythroblastosis fetalis that were similar in every
way to those due to Rh incompatibility except that no Rh
agglutinins could be demonstrated in the maternal circula-
tion. The explanation for such phenomena became apparent
in 1944 when both Wiener and Race demonstrated the Rh block-
ing antibody. In testing the sera of patients reacting to
intra-group transfusion reactions or those of mothers of
erythroblastotic infants for Rh sensitization, Wiener-*-^
found that by the usual agglutination test, no antibodies
could be demonstrated. However, when a drop of known active
anti-Rh serum was added to the known cell-test serum mixture
the Rh positive red cells were not agglutinated^ indicating
that a reaction had occurred at the sites of Rh antigen on
the red cells with antibodies of the unknown serum. The
reaction was found to be specific for Rh positive red cells,
occurring only with sera from Rh negative people sensitized
to the Rh factor.
Race*^^ discovered the blocking antibody when studying
mixtures of different types of human anti-Rh sera. The
.-
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initial observations that led to this discovery were as
follows: Anti-D serum reacts with CDe and cDE cells# Anti-
CDe serum agglutinates CDe cells but not cDE cells. If cDE
cells were added to a mixture of the two sera, no agglutina-
tion occurred, contrary to the reaction that should have been
observed due to the presence of the anti-D serum# Similar
findings were found without mixing the sera# When cDE cells
were suspended in anti-C serum without agglutinating, then
separated, washed, and resuspended in saline, these cells
could no longer react with anti-D serum# CDe cells could
also be coated with this incomplete antibody* Agglutination
of the coated cells did not occur when the pH and salt con-
centrations were varied. When a mixture of complete and in-
complete anti-D antibodies were titrated, the titer was the
same as v/hen the serum with the complete antibodies was ti-
trated except that the strength of reactions with the former
was much weaker. This observation indicated that the in-
complete antibodies reacted more rapidly with the antigenic
sites of the red cells than the complete antibodies.
34Diamond and Abels on found an Rh inhibitor substance
in anti-Rh sera that inhibited anti-Rh agglutinins. This
inhibitor substance is equivalent to Wiener’s blocking, and
Race’s incomplete antibody. In addition to anti-D blocking
antibodies, anti-E and anti-c blocking antibodies were also

demonstrated. These workers showed that the degree of in-
hibition of agglutinins by blocking antibodies depended
upon the relative amounts of these two antibodies present
in a serum or mixture of sera. In an in vivo experiment
they confirmed the finding that anti-Rh agglutinins may be
completely masked by the inhibitor substance. Pooled serum
that showed no agglutinins was injected intravenously into
a CDe/cde person. Afterwards tests of the individual’s
blood showed free anti-D agglutinins in the serum, and some
of the cells were inagglutinable, indicating that they were
bound by the inhibitor substance. Similar results were ob-
tained in vitro with the same serum and cells. When one
part of cells was added to one or more parts of serum, no
agglutination occurred. As the cell concentration was in-
creased, agglutination became apparent. These findings led
the authors to test the sera of sensitized women that showed
no anti-Rh agglutinins with an excess of cells. Agglutina-
tion of Rh positive cells occurred.
35
Diamond and Abelson’s observation that anti-Rh agglu-
tinins masked by an inhibiting substance in a serum could be
demonstrated if tested against a higher concentration of Rh
positive cells led to the development of the slide test.
According to the authors the mechanism depends on the high
cell concentration which leaves sufficient unblocked sites
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on the red cells for action of the agglutinins. However,
Wiener'1'68 has demonstrated that Diamond and Abels on’s slide
test was positive when only blocking antibodies and no
agglutinins were present in the serum, thus ruling out the
latter authors’ idea that the agglutinins were unmasked.
The authors stated that the method could not be used for
Rh typing, Wiener pointed out that their slide test could
be used for typing if antisera containing separate or pure
antibodies were used. For instance, a pure anti-C, not a
mixture of anti-C agglutinins and anti-D blocking antibodies,
would have to be used, for this test permits both agglutinins
and blocking antibodies to act. Other authors were unable
to repeat the slide test using saline suspensions of 40-50
rzn
per cent washed erythrocytes. Also Diamond and Abelson
were unable to repeat their original results using cells
suspended in saline. Wiener^- and Levine and Waller
demonstrated that the determining factor was the use of
serum as the suspending medium rather than saline,
A second slide test, recommended by Simmons-1-22
,
employs
a 5 per cent red cell suspension in Rous-Turner solution.
As indicated above, blocking antibodies can be demon-
strated directly by the test tube method when various media
are substituted for saline both for suspending the red cells
and for diluting the sera. Wiener^® in 1945 substituted
*p
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Group AB or compatible human serum or oxalated plasma for
saline, and called the procedure the ’’conglutination” test#
Since the test worked equally well with fresh and with
heated serum, and with plasma inactivated for 1/2 hour at
60 C, complement was not involved* Since slight dilution
of the serum or plasma with saline weakened or eliminated
the reaction the cells were not washed with saline* Later,
Wiener advised washing the cells once with saline, then
o R
suspending them in the serum or plasma* Levine and Waller*'
obtained the same finding using serum as the suspension
medium* Wiener’s^'® routine procedure was to test the sera
first for agglutinins. If negative, the tube was centrifu-
ged, the supernate removed, and replaced by a drop of com-
patible serum or plasma* The tube was then re shaken, incu-
bated at 37 C for one hour, and read.
Boorman, Dodd and Morgan® in 1945 also reported on
the enhancing properties of compatible human sera on the
agglutination of Rh positive red cells by Rh antibodies,
but did not record the existence of previously unrecognized
antibodies. They found that the plasma or serum of dif-
ferent individuals varied in their ability to enhance agglu-
tination. In 1947 Wiener and Hurst^ 5® substituted a com-
bination of oxalated plasma and 25 per cent human albumin
in a proportion of 4 to 1. They found that the addition
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of albumin to plasma increased the sensitivity of the re-
action* Wiener155 postulated that the mechanism of the
test depended upon the presence of X protein, a molecular
complex of albumin, globulin and phospholipid, in the serum
or plasma* However, some other mechanism must function
since colloidal substances work equally well*
There are conflicting reports concerning the use of
umbilical cord serum as a suspension medium for the red
cells and a diluent for sera in testing for the presence
of Rh blocking antibodies. As seen below, the observations
of various workers indicate that this discrepancy is due to
qqindividual variation among cord sera* Lubinski* 57 stated that
cord sera could not be used to demonstrate the incomplete Rh
antibody* On the other hand, Levine stated that human cord
serum was not much less sensitive than pooled male serum as
a suspension medium, and that certain cord sera are prefer-
able to selected male sera*
Gurevitch, Polishuk and Hermoni 5^ studied the activa-
ting effect of sera from infants of different age groups,
and normal, pregnant, and diseased adults, on Rh blocking
antibodies when substituted for saline* The blocking anti-
bodies were obtained from two women who gave birth to ery-
throblastotic infants, one having an agglutinin titer of
1:8 and a blocking titer of 1:64, and the other an agglutinin

titer of 1:128 and a blocking titer of 1:256. It is doubt-
ful that blocking antibodies actually were present since a
1 tube difference is well within the range of error of the
test. The results when tested against the first serum were
as follows: Of the 41 cord sera, 38 were weak and 3 activa-
ted the blocking antibodies like mature sera. Of 11 sera
from infants ranging from 1-6 months of age, 10 were weak
and 1 was mature. Of the 10 sera from infants ranging from
6-18 months of age, 1 was weak and 9 were mature. The sera
from the normal adults, pregnant women, and adults with
hepatic diseases were fully active. The authors concluded
that the enhancing properties of mature human sera were not
influenced by pregnancy or by cirrhosis or hepatitis of the
liver. This property was not found in cord blood or in in-
fants 1 blood up to 6 months of age.
In 1947 Witebsky, Rubin and Blum-*-63 found that the en-
hancing properties of fetal and infant sera on Rh blocking
antibodies varied with the Rh serum and with the cord serum.
Varying activity among umbilical cord sera was demon-
strated with a serum containing only blocking antibodies to
a titer of 1:320 from a mother of an erythroblastotic in-
fant. Three adult human sera, one of Group 0, one of Group
A, and one of Group B, and three cord sera were used both
to dilute the serum and to suspend the Group 0, Rh positive
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test cells. The adult sera gave a blocking titer of 1:320,
One cord serum gave a titer of 1:5, a second 1:20, and the
third 1:160, There is also variation among anti-Rh sera
in their ability to be activated by cord sera, and the capa-
city of cord serum to activate the blocking antibody also
varies with the Rh antiserum tested. The serum of a mother
of an erythroblastotic infant was compared with a commer-
cial anti-Rh serum, which the authors assumed was produced
by immunization of Rh negative volunteers with Rh positive
cells. Reactions with the maternal serum produced a titer
of 1:40 with the 3 normal adult sera, and no agglutination
with the 3 normal cord sera, When the same normal adult
and normal cord sera were used with the commercial Rh anti-
serum, all 6 showed a titer of 1:40, The authors suggest
that these differences may depend on the titer of anti-Rh
antibodies in the different sera and on the method of immu-
nization, The activating capacity of the sera of premature
infants was tested against a commercial anti-Rh blocking
serum. When activated by Group 0, A and B normal adult
sera, a titer of 1:80-1:160 was observed. Of the prema-
ture sera, 1 six-month premature serum activated the block-
ing serum to a titer of 1:5, 2 eight-month 1:5 and 1:10,
1 two-week premature 1:20, 1 one-week premature 1:10, Of
3 full term, 2 activated the Rh antiserum to a titer of
1:40, 1 to 1:80, It can be seen that part of the activa-

ting capacity of sera of premature infants depends upon the
age of the fetus, "Obviously a maturation factor plays a
definite role in the appearance of the characteristics res-
ponsible for the activation of the incomplete Rh antibody—
”
The effect of maturation in post-natal life was studied
in (a) cord serum, (b) serum from venous blood 24 hours after
birth, and (c) serum from venous blood 43 hours after birth.
The anti-Rh blocking serum with a titer of 1:320 was from a
mother of an erythroblastotic infant. None of the 3 samples
of 1 infant showed any activating capacity; only the 48-hour
sample from a second infant, and both 24 and 48 ho ’or samples
from a third infant activated the blocking antibody. From
the testing of premature, cord, 24 and 48-hour serum samples,
it is apparent that the activating power of serum depends upon
¥
a maturation factor. However, because of individual variation
it would be impossible to predict the activating power of a
fetus’ or infant’s serum at any particular time.
There is a difference between adult and cord sera in
total protein, albumin and globulin. On the average cord
sera contained about 1 g per cent less of total protein and
l/2 g per cent less of albumin and globulin than in the
average adult serum. However, some of the cord sera which
had poor capacity to activate Rh blocking antibodies had
serum and globulin levels comparable to those of adult sera
-'
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that had a good activating capacity. A more complete chemi-
cal study of the serum protein fractions may reveal other
differences. For examination of sera of Rh blocking anti-
bodies, only those infants’ sera that showed a capacity to
agglutinate sensitized cells equal to that of adult sera
should be used.
In using plasma as a medium for Rh testing. Diamond and
Denton33 had trouble with rouleaux formation. This inter-
fered with the macroscopic and microscopic reading of the
test and with the determination of the end point in carry-
ing out titrations. Human and bovine crystalline albumin
gave reactions that were as sensitive as those with plasma,
and were superior to those of plasma in that the clumping
was firmer and more distinct, and there was no tendency
toward rouleaux formation. Since bovine albumin was more
available and cheaper, this was the medium of choice.
The critical concentration of albumin was a 20 per
cent solution. Below this concentration reactions were
weak or absent. Above 30 per cent viscosity made the solu-
tion unusable. A 30 per cent solution was the concentra-
tion of choice. Good agglutination occurred when the cell
concentration was varied from 2 to 50 per cent. The 2 per
cent was easiest to use and read. When the influence of salt
content was investigated, hypotonic solutions of albumin pro-
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duced swelling and hemolysis of the cells, but isotonic
and hypertonic solutions gave good results. When the rate
of antigen-antibody reaction was studied, agglutination
was grossly visible in 1 minute and completed in 15-30
minutes at 37 C. At room temperature completion of the
reaction occurred between 30 and 60 minutes. Sera contain-
ing only agglutinins, only blocking antibodies, and a com-
bination of the two were compared, using both saline and
albumin technics. If only agglutinins were present, the
saline and albumin tests gave approximately the same titer.
If only blocking antibodies were present, no reaction oc-
curred In saline but strong agglutination took place in
albumin. If a combination of the two were present, this
was indicated by a difference in titer between the saline
and albumin tests.
The effect of cerebrospinal fluid on the reaction
between Rh antibodies and their antigens was studied by
Jacobowicz and Bryce. Human sera containing agglutinins
with titers ranging from 1:64 to 1:2,000 were obtained from
mothers of erythroblastotic infants. Blocking antibodies
were present in 2 of the 6 sera. When 15 different speci-
mens of cerebrospinal fluid were substituted for saline, 3
sera did not agglutinate Group 0 Rh positive cells, 1 was
completely inhibited by 6 and partially inhibited by 2 of
the 15 cerebrospinal fluids, and 2 anti-Rh sera were par-
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tially inhibited. Since the 6 sera were not affected by
the cerebrospinal fluids to the same degree, this would
indicate that the inhibition of agglutination was partly
due to a variable factor in the different specimens of se-
rum, When the cerebrospinal fluid was replaced by saline,
strong agglutination of the cells occurred. Thus, the
cerebrospinal fluid had no effect on the Rh positive cells,
but interfered with some component of the serum. When
cerebrospinal fluid was used to dilute the anti-Rh serum,
and the cell suspensions were made up in human serum or 25
per cent human albumin, the effect of the cerebrospinal
fluid was partially counteracted by the serum and completely
eliminated by the albumin. Later additions of human serum
to tests carried out with cerebrospinal fluid caused the
reappearance of agglutination, indicating that the inhibi-
tion is reversible, at least to a certain degree. Cerebro-
spinal fluids from rabbits and from a rhesus monkey gave
similar inhibition. No inhibition was observed with arti-
ficially prepared fluids containing the main known chemical
components of cerebrospinal fluid or with the chemically
similar allantoic fluid from chick embryos. The factor in
cerebrospinal fluid causing inhibition is heat stable. It
was not destroyed by 56 C or 62 C for l/2 hour or boiling
for 5 minutes.
Gelatin.- Diamond and Denton33 found that their solu-

tions of gelatin clumped both Rh positive and Rh negative
cells. Levine made the proviso that certain varieties of
gelatin could be used for direct testing for blocking anti-
bodies. Fisk and McGee43 found a special brand of gelatin
satisfactory both for the determination of the presence of
agglutinins and/or blocking antibodies and for titrations
of the antibodies. This method was used to test 96 sera
from Rh negative women. Thirty-two of the specimens were
positive. These were found to contain blocking antibodies
in varying titers and several contained agglutinins. The
64 negative sera were also negative when saline and plasma
were used as the test media. Twenty antisera were titra-
ted simultaneously using gelatin and plasma. The 2 media
gave parallel results.
In 1945 Coombs, Mourant and Race22 published a pre-
liminary note describing an indirect and a direct test for
detection of incomplete or blocking Rh antibodies. The
same year a more detailed study appeared." The essential
mechanism of their test is based on the reaction of an
anti-antibody against antibody specifically attached to
red cells, as seen below. The direct test is useful in
determining whether red cells have been sensitized in vivo
by the incomplete antibody. The test was referred to in
22the original communieation of Coombs, Mourant and Race
2 5in 1945, and was described more fully in 1946." In the
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indirect test the materials were set up as for the detec-
tion of agglutinins. If there was no evidence of agglu-
tination, the cells were washed 3 times with saline to
remove all human serum and resuspended in 2 drops of saline.
Two drops of an appropriate dilution of rabbit’s anti-human-
globulin serum previously absorbed with a mixture of human
Group A, B and 0 cells were added and the test reincubated
at 37 C for 1/2 hour. The tests were then read. If the
cells were sensitized with incomplete Hh antibodies in
the first part of the test, the rabbit's anti-human-glo-
bulin serum reacted with the human globulin on the red
cells and cause clumping. Rabbits’ sera reliable for the
test after absorption with Group A, B, and 0 cells were*
rabbit's anti-human pseudoglobulin, rabbit’s anti -human-
globulin, and rabbit's anti-human-whole-serum sera. A
more detailed study appeared in 1947 in which both the
antigen injected and the injection schedules of the rabbits
were varied. The criterion used for an agglutinating dose
was the smallest amount of antisera giving a 2
-/ reaction.
For routine testing, 8 agglutinating doses were used. Group
0 serum was used to eliminate the production of undesirable
anti-A and anti-B antibodies in response to dissolved A and
B antigens in human seraof the other groups. Anti-alum-
precipitated-human-serum sera were satisfactory. Fewer in-
jections were necessary to produce a high titer. Normal

rabbits’ sera had no effect on the sensitized cells. The
reaction was not due to a nonspecific colloidal effect of
immune sera in general, for high-titered rabbit’s anti-
typhoid and anti-pneumococcus Type 2 sera had no effect on
sensitized cells.
Rabbits’ antisera were prepared against albumin,
alpha and beta globulin, and gamma globulin from human
serum. After inactivation at 56 C for l/2 hour and absorp-
tion with Group A, B and 0 cells, the antisera were tested
to see whether they were specific for their respective anti-
gen fractions by the precipitin flocculation test. Before
and after neutralization with the different protein frac-
tions of human serum, the antisera were tested for their
ability to agglutinate red cells sensitized with incomplete
Rh antibody. Antisera against different protein fractions
of human serum were not specific for their respective frac-
tions when examined by the precipitin flocculation test.
When albumin was used to neutralize the different sera,
there was no reduction in agglutinating titer of the sensi-
tized cells. Neutralization with gamma globulin completely
removed the ability of the sera to agglutinate sensitized
cells. When alpha and beta globulin were used to neutra-
lize the sera, only a slight reduction of titer occurred*
The authors suggested 2 possibilities for this reduction.
One was that there might have been traces of gamma globulin
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in the alpha and beta globulin used for neutralization, the
second, that a small part of the Rh antibody might be con-
tained in the alpha and beta globulin fractions of human
serum. Prom this serological evidence it appeared that the
antibody in rabbit's anti-human-globulin serum which agglu-
tinated red cells sensitized by incomplete Rh antibodies
was an anti-gamma-globulin antibody, and that the incomplete
antibody was present in the gamma fraction of human serum.
It could not be stated that a small amount of incomplete
antibody was not contained in the alpha and beta globulin
fractions. Further evidence for the presence of the in-
complete Rh antibody in the gamma fraction of human serum
was obtained from chemical studies. Human serum containing
incomplete antibodies was treated with ammonium sulfate.
The fraction precipitated at 33 per cent saturation, which
contains most of the gamma globulin, contained most of the
incomplete antibody. The fraction precipitated between 33 and
50 per cent which contains most of the alpha and beta, as well
as some gamma globulin, also sensitized red cells, but not
as strongly as the first fraction. The albumin fraction of
the human sertun did not sensitize the cells at all. The
above data would indicate that the incomplete antibody was
contained mainly, if not entirely, in the gamma globulin frac-
tion of human serum. Simmons^^ published a report on the use
of rabbits’ precipitating antisera to species other than human.
--
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for agglutinating human red cells sensitized by incomplete
Rh antibodies. The following antisera prepared in rabbits
gave positive results with sensitized red cells and negative
results with normal cells: anti-human, anti-porcine, anti-
feline, anti-equine, anti-caprine, anti-canine, and anti-
bovine. Anti-galline gave negative results.
The elution of antibodies from cells to which they
are attached and demonstration of the antibodies in the
supernate is a method which can be used to indicate the
presence of agglutinins and/or blocking antibodies absorbed
onto the surface of red cells. The elution technic is that
of Landsteiner and Miller, 175 and adapted to the study of Hh
CQ
antibodies by Haberman and Hill. ° A somewhat different mo-
15difi cation was suggested by Carter and Loughrey. As indi-
cated in both papers, agglutinins could only be obtained
from cells of Rh positive infants born to Rh negative mothers
in whose serum Rh agglutinins were demonstrable. Wheeler and
137Scholl carried out a more detailed study on the optimal
conditions for the release of Rh agglutinins from the red
cells. When varying the pH of the saline used for suspending
the red cells from 6.3 to 7.8, they found that the best re-
sults were obtained when the pH was at 7.0. The actual range
of temperature, from 45 to 55 C, had little influence on the
amiount of antibody released. 45-50 C was preferable because
t
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the amount of hemolysis was much less at 50 C or below.
The duration of heat treatment was important in relation to
the amount of antibody released. An increasing amount of
agglutinin was released by 10-30 minute exposures to heat,
accompanied by increase in hemolysis. For routine testing
a 30-40 minute heating interval was used.
No incomplete or blocking antibodies could be demon-
137
strated by the above technic. However, Wheeler and Scholl
fecund that if a 20 per cent solution of bovine albumin was
substituted for saline during heat treatment and for sus-
pending the test cells, blocking antibodies could be demon-
strated in the eluate.
Stimulated by the lack of Rh typing antisera, Chown20
devised the capillary method of Rh testing, Berlin2 publi-
shed a modification of this method. Since no saline or other
extraneous crystalline solution was used, this method, if
known cells and unknown serum were used, would indicate the
presence of both agglutinins and blocking antibodies, Krie-
74ger and Weiden found this method unreliable. When com-
pared simultaneously with the Simmons slide test, there were
58 discrepancies out of 150 bloods tested. The method was
also investigated in Boyd’s laboratory and found to be very
difficult to read.
.
The specific hemolytic action of Rh and Hr aggluti-
nins and blocking antibodies (their " cryptagglutinoids"
)
on corresponding red cells in the .presence of complement
was demonstrated by Hill and Haberman65 and later by Hill,
Haberman and Jones . 66 Little hemolysis occurred without
the addition of complement. The amount of hemolysis was
increased by gently shaking the mixture of anti-Rh serum,
Rh positive blood and complement. In comparing the effect
of different titers of both agglutinins and blocking ("cryp-
tagglutinoids") antibodies, they observed that as the titers
of the two kinds of antibodies were increased, "the hemoly-
tic effect became more marked with relatively good corre-
lation of titer and hemolysis."
Nature of Rh Antibodies .- Both agglutinins and block-
ing antibodies are proteins. Diamond and Abelson5^ found
that they are precipitated by heat or alcohol. That they
are both globulins was shown by chemical fractionation
studies, anmonium fractionation studies, and by Witebsky’s
method for the concentration of Rh agglutinins. All studies
agree that the agglutinins are present in the gamma frac-
tion, but disagree as to the location of the blocking anti-
bodies. The ehemical fractionation studies
,
55 in which Cohn
methods 2 -1-9- have been applied, indicated that the agglutinins
were present in the gamma globulin fraction. Most of the
blocking antibodies were found in the beta fraction, with
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small amounts present in the alpha and gamma fractions.
According to studies using different concentrations of
ammonium sulfate, 26 the blocking antibodies are in the
gamma fraction. This fraction contained most of the
blocking antibodies. The fraction containing mostly
alpha and beta globulins and some gamma globulin, yielded
some blocking antibody, but less than the first precipi-
tate. Dialysis of a human serum^-62 containing both agglu-
tinins and blocking antibodies separated the serum into 2
parts. The precipitate, which consisted mainly of globu-
* *
lins, contained the Rh agglutinins. The super nate, which
was largely made up of albumin and some globulin, contained
most of the blocking antibodies.
Coombs and Mourant26 studied the chemical composition
of the blocking antibodies by serological methods. These
consisted of identifying the serum fraction needed to agglu-
tinate red cells sensitized by blocking antibodies. They
used the inhibition technic. Different fractions of human
plasma were added to the rabbit-anti -human-globulin serum
prior to addition to the sensitized cells. Neutralization
by albumen did not reduce the agglutinating titer of the
rabbits’ antisera. The titer was completely removed by
gamma globulin, but only slightly reduced by alpha and beta
globulins. This was probably due to the presence of a small
amount of gamma globulin precipitated along with the alpha
and beta globulins.
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A serum containing agglutinins and "developing anti-
bodies" to a titer of 1:4,000 and a blocking titer of 1:2
(Wiener’s original inhibition method) was studied electro-
phcretically. 66 The albumin and globulin fractions were
tested for the presence of antibodies. These were found
in the gamma globulin. It is to be regretted, in view
of Diamond’s localization of blocking antibodies in the
beta globulin, that Hill, Haberman and Jones did not also
study a serum high in blocking antibody content. It also
would have been of interest to study sera containing anti-
bodies demonstrable only by the Coombs test, Coombs and
04
Race found that Rh positive cells exposed to agglutina-
ting and to blocking antibodies showed the same migration
in an electric field. From this they concluded that the
surface charge could not be the only factor causing clum-
ping by agglutination. They also found that blocking
antibodies could not go through a collodion filter per-
meable to proteins whose molecular weight was 30,000A°.
Ultracentrifugal studies seem to indicate that agglutinins
are smaller than blocking antibodies .36
To summarize, agglutinins are gamma globulins. This
*
is indicated chemically by chemical fractionation studies,
fractionation studies making use of different percentages
of ammonium sulfate, and by dialysis of serum. An electro-
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phoretic study localized agglutinins in the gamma fraction#
Serologically antibodies demonstrated by the Coombs technic
were found in the gamma globulin fraction. Blocking anti-
bodies have been localized by Diamond in the beta globulin
fraction.
Agglutinins and blocking antibodies react differently
to various physical agents. When exposed to heat blocking
antibodies are more stable than agglutinins# Diamond and
Abelson^ found that prolonged exposure to 56 C would in-
activate anti-Rh agglutinins but have little effect on
blocking antibodies. Coombs and Race24 found that blocking
antibodies would withstand 65-70 C for 5-10 minutes. Wiener
157
and Handman made use of this property in their method
for detecting blocking antibodies in sera containing a com-
bination of the two kinds of Rh antibodies. Exposure of
an alliquot of the serum under examination to 60 C for 1/2
hour completely destroyed the agglutinins, but resulted in
only moderate deterioration of the blocking antibodies.
gBoyd exposed anti-Rh agglutinins to pressures of 3,000-
0 * J
4,000 atmospheres. Agglutinating ability was destroyed, but
such pressures did not convert agglutinins into blocking
antibodies. Higher pressures of 4,500 to 5,000 atmospheres
were required to destroy blocking antibodies. Photo-oxida-
tion of anti-Rh agglutinins in the presence of eosin - Y as
.
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sensitizer destroyed their agglutinating ability in 15 1/2
hours .9 There are conflicting reports on the effect of
merthiolate solutions on agglutinins* Waller , x and Dia-
mond and Abe Ison34 found that anti-Rh agglutinins are in-
activated and blocking antibodies are not affected* How-
ever. Landsteiner and Wiener added merthiolate to their
guinea pigs' anti-rhesus agglutinins as a preservative, and
124Simmons and Graydon found that Rh agglutinins to which
merthiolate had been added were active many years later*
When saline is present agglutinins will cause clumping of
the red cells* Blocking antibodies will coat, but not
clump the red cells in saline when the proportion of saline
diluent to the total content of the tube reaches approxi-
*z rz
mately 1/3* Both agglutinins and blocking antibodies
will cause agglutination of Rh positive red cells in various
colloidal solutions.
Agglutinins and blocking antibodies also differ in
their immunological characteristics • Agglutinins are found
in humans immunized by transfusion of blood incompatible
for the Rh factor or by immunization of a mother whose fetus
has incompatible red cells. They are also found in the
serum of animals who have responded to injection of Rh posi-
tive red cells. So far, blocking antibodies have been found
only in humans. Diamond and Denton33 stated that one of
*-
.
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their guinea pig-anti-rhesus sera shored a significant
amount of blocking serum. This v/as based on the fact
that the clumping of cells was much stronger in albumin
* *
than in saline. However, there was only a one-tube dif-
ference in titer which is within the error inherent in the
method. Most workers state that agglutinins are "early" or
"immature" antibodies, and that blocking antibodies are
"late" or "mature" antibodies. This is based on the early
anpearance of agglutinins and the later appearance of block
-
ing antibodies in actively immunized humans, However,
when Van Loghenr^ actively immunized Rh negative male volun-
teers, one exception v/as found in whom only blocking anti-
bodies were formed without preceeding formation of aggluti-
nins, It has been implied that blocking antibodies can be
found in the serum of an individual longer than agglutinins.
No careful studies of various individuals over a long period
of time have been carried out. Since the kinds and amounts
of antibodies are so variable among individuals, a large
enough group would have to be followed to obtain statisti-
cally significant results.
The 2 types of antibodies also evidence different sero-
logical characteristics. If both Rh agglutinins and Rh block
ing antibodies of the seme specificity are present in a serum
the blocking antibodies react more rapidly than agglutinins
#.
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with their antigen on the red cello" This is observed if
there is not a masking of the blocking antibodies by a much
greater concentration of agglutinins, when the test is done
in saline.'1' 5
'
7 Another indication is the number of absorp-
tions needed to remove specific antibodies from a serum.
Levine and Waller95 found that blocking antibodies could be
removed by a single absorption with specific red cells.
Several treatments were necessary for the complete removal
of agglutinins. Both agglutinins and blocking antibodies
are reversibly attached to the red cells since the applica-
tion of heat will cause the release of antibody into the
supernate. 15 * 58 *-1- 5
’7 According to Witebsky-1- 65 the strength
of agglutination of red cells by blocking antibodies rarely
reaches the strength of agglutination of red cells by strong
agglutinins. Wiener^ has stated that the specificity of
the red cells involved differs. Cell aggregates caused by
*
agglutinins are specific, that is, they contain only 1 type
of cell, whereas clumps formed by blocking antibodies con-
tain more than 1 type of cell. He also reported^ that Rh
agglutinins do not fix complement and lyse cells, but that
blocking antibodies do. However, Hill, Haberman and Jones
found that agglutinins and blocking antibodies cause speci-
fic hemolysis of red cells in the presence of complement
under the conditions of their experiment.
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Whether agglutinins and blocking antibodies differ
in their clinical significance has not been determined.
Wiener stated'3’47 that the placenta is permeable to "uni-
valent" blocking antibodies, but holds back "bivalent"
agglutinins. Blocking antibodies could be found in the
blood of a high percentage of infants whose mother’s serum
contained blocking antibodies, but agglutinins have been
demonstrated in infants’ bloods. It is quite possible that
Wiener’s impression is caused by the fact that blocking
antibodies are found more frequently in maternal sera. He
also observed'3’4® that blocking antibodies are the major
cause of erythroblastosis fetalis due to Hh incompatibility
between mother and infant, agglutinins being a very minor
cause of this condition. However, not all workers in the
field share this viewpoint.
Both Hill and Haberman, and Wiener believe that they
have evidence for a third order antibody. Hill and Haberman66
observed differences in the demonstration of antibodies and
in their strength when testing sera by the agglutination,
* s
inhibition, and Coombs technics, and they thought that the
difference between the three tests indicated that the basic
character of the Rh antibodies must be different.
Hill, Haberman and Jones have presented date based on:
(1) studies on mothers with erythroblastotic infants; (2) anti
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body patterns found during deliberate hyperimmunization;
(3) investigation of changes in antibody characteristics
during deterioration in vitro over a period of time;
(4) the demonstration of the hemolytic action of the Rh
antibodies, especially the third order or " cryptaggluti-
noid" type to establish their antibody nature; and (5)
electrophoretic studies to determine whether agglutinins
and " cryptagglutinoids" were in different protein fractions
Evidence for a third order antibody was presented on all
points, but no proof has been demonstrated. A statement
made by these authors seems to the writer so applicable
to the field of Rh antibodies in particular that it is
quoted in full. "It would seem apparent that the forces
involved in the antigen-antibody reactions are so closely
linked to physical chemistry that attempts to represent
pictorially these activities on the basis of the know-
ledge at hand is pure speculation."
Wiener’s evidence is based on the ratios of titers
when determined by the inhibition or indirect test for
blocking antibodies, by the direct test for blocking anti-
bodies using plasma as the medium, and by the direct test
for blocking antibodies using albumin-plasma as the medium.
The existence of a third order antibody awaits proof.
-.
. <
«
-
_
.
-
Three methods of concentrating Rh antibodies have
been used. The method carried out in Cohn’s laboratory is
too involved for general use. Tv/o other methods, one sug-
gested by Witebsky, Mohn, Howies and Ward and the other
24by Coombs, Mourant and Race can be applied in any labora
tory.
Witebsky ’ s method is useful for concentrating agglu-
tinins and for partly removing blocking antibodies that
may be present in the same serum. The procedure is to dia-
lyze serum containing Rh agglutinins. The precipitate is
composed mainly of globulins. It is sedimented and redis-
solved in l/lO the original volume of saline. This method
can be used to make ordinarily weak sera usable for diag-
nostic typing.
Coombs, Mourant and Race’s method is based on the
fact that saturation of the serum with a 25-33 per cent
ammonium sulfate will precipitate most of the gamma globu-
lin.
The specificity of the Rh antibodies is indicated below.
In animals only agglutinins corresponding to anti-D have been
demonstrated.
Humans differentiate among the various Rh antigens
much more readily than animals. This is indicated by the
.—
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wide varieties of Rh antisera produced by the introduction
of cells incompatible for the Rh factor into the blood
stream of man. The following are Rh antisera that have
been demonstrated to date:
anti-C, anti-Cw
,
anti-Cu
anti-c, anti-cv
anti-D, anti-Du
anti-d
anti-E
anti-e
The reactions of humans to Rh antigens are dealt with
more fully in the section under Rh antigens.

PRESENT INVESTIGATION
Rationale The general conclusion which emerges
from a survey of the present literature is that the Rh
factors, at least when administered in the usual way,
are poor antigens in experimental animals* The most
potent animal antisera obtained cannot approach the
strength and avidity of good human anti-D sera. In man
the best anti-Rh sera are produced by mothers of erythro-
blastotic infants* If one assumes that the fetal antigen
enters the maternal circulation at least during the latter
part of the pregnancy, an ideal situation for immunization
is present. The reactive organism is continuously stimu-
lated by small amounts of antigen over a long period of time
Increasing use has been made of adjuvants to enhance
antigenic stimulation* When the antigen is suspended in
the water phase of a water-in-oil emulsion it seems to be
released more slowly and over a long period of time. Mudd
and Smolens injected mice subcutaneously with Shigella anti-
gen in a water-in-oil emulsion. Material from the site of
injection was introduced into fresh mice after various time
intervals • They found that the amount of the deposited
vaccine diminished within 2 weeks, but that traces of the
antigen were still demonstrable 22 weeks after injection.
Freund, who has investigated the role of both paraffin oil
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and tubercle bacilli in water-in-oil emulsions, observed
that paraffin oil increased and prolonged antibody forma-
tion, but had little effect on sensitization, and that
Mycobacteria increased antibody formation and altered
sensitization.
Adjuvants have been successful in stimulating anti-
body production in a number of situations. Their use has
increased the titer and prolonged the activity of anti-
bodies against the typhoid bacillus and against the diph-
theria toxoid. However, the addition of tubercle bacilli
exerted little effect over and above that contributed by
the paraffin oil and emulsifier. Water-in-oil emulsions
containing tubercle bacilli have also been effective in
immunizing against influenza and Japanese B encephalitis
viruses, against epidemic and murine types of typhus vac-
cines, and against malaria. Antibody formation to poor
antigens such as alcoholic extract of brain, histaminazo
protein, and ragweed pollen was enhanced by suspending
the antigen in the water-in-oil emulsion containing tuber-
cle bacilli.
Since the Rh antigens are poorly antigenic, and since
antibody formation by other weak antigens has been enhanced
by incorporating them into the water phase of a water-in-oil

emulsion containing tubercle bacilli, the following
attempts have been made to produce usable Rh antibodies
in animals, employing adjuvants with the poorly antigenic
Rh antigens.
EXPERIMENT I Macacus rhesus erythrocytes as the
antigen.
Selection of Animals ,- Smooth-haired guinea pigs
(550-950 g) were divided according to the weight and color
as evenly as possible into two groups of 5 each. Group 1
received whole rhesus red cells incorporated into the water-
in-oil emulsion. Group 2 received rhesus stroma in the
emulsion. Also rabbits (8-10 lbs.) in 2 groups of 5 each
received similar injections.
Preparation of Antigens .- Rhesus erythrocytes sus-
pended in sodium citrate were kept in the refrigerator for
5 days before use. Preliminary tests on the technic of
preparation of antigens were made first with the more
readily available horse erythrocytes. For the preparation
C ]
of stroma partial use was made of Heidelberger ’ s method
but freezing and thawing were eliminated, for nothing was
known of the action of these procedures on the Rh antigen,
100 ml of defibrinated horse blood was centrifuged in the
refrigerated centrifuge at 40 F at a speed of 4500 r.p.m.
for 10 minutes. The plasma was removed and the cells washed
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3 times with 0.9 per cent NaCl. 41 ml of packed horse
erythrocytes were poured into 10 volumes of chilled dis-
tilled water saturated with CO2 while chilled. The material
was centrifuged as above and the supernate removed. The
volume of the pink viscous sediment was still 41 ml. The
material was then washed 5 times with 0.2 per cent NaCl.
At the end of the procedure it was puzzling to find that
the volume was still the same. As a check the same proce-
dure was carried out with fresh human erythrocytes with
similar results.
The rhesus erythrocytic antigens were prepared as
above, using sterile precautions. After 3 v/ashings with
0.9 per cent NaCl, 20 ml of whole packed red cells were
set aside for Group 1 of the guinea pigs and Group 1 of
the rabbits. The remaining 52 ml of packed rhesus ery-
throcytes were poured into 10 volumes of chilled sterile
distilled water. The sedimented stroma were used as anti-
gen for Group 2 of the guinea pigs and rabbits. No Sharp-
ies centrifuge was available at the time. Again, using
rhesus erythrocytes, there was no change in volume follow-
ing treatment of the red cells with distilled water.
Preparation of Emulsion .- See p.75under Experiment II.
Injection Schedule .- Groups 1 and 2 of guinea pigs
.*
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TABLE III
Experiment I
Material Injected per Animal
Total amount Whole packed
Group material red cells Stroma Falba Bayol P t.b.
injected
ml ml ml ml ml mgm
1 3 1.2 0.6 1.2 0.2
2 3 1.2 0.6 1.2 0.2
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and rabbits received the same injection schedule* Two
series of inoculations were given. On 3 successive days
of the first week of the experiment each animal received
0.5 ml of emulsion in the nuchal regions, alternating
between right and left. Each 0.5 ml was divided into two
0.25 ml injections given simultaneously.
Bleeding Schedule .- See p. 75under Experiment II.
EXPERIMENT II Human Group 0, MN, Rh -/ erythro-
cytes as the antigen.
Selection of Animals .- Smooth-haired guinea pigs
(500-1,000 g) were distributed according to weight and
color as uniformly as possible in 6 groups of 10 each.
The antigen given to Groups 1, 2, and 3 was prepared from
whole packed human Group 0, type MN, Rh -/ erythrocytes.
Stroma prepared from the same pooled cells were injected
into Groups 4, 5, and 6. Groups 1 and 4 were injected
intraabdominally with plain antigens. Groups 2 and 5 sub-
cutaneously with the antigen in a water-in-oil emulsion,
and Groups 3 and 6 received the emulsion intraabdominally.
Preparation of Antigens .- Four liters of human Group
0, type MN, Rh -/ (all 3 Rh antigens, rh', Rh°, rh" (C, D
and E) were present) erythrocytes pooled from 18 separate
individuals were used as the antigen. The whole packed red
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TABLE IV
Experiment II
Groups of Guinea Pigs Used*
Material injected
Form Route
Whole cells-*-* Stroma
Group 1 Group 4 Plain Intraabdominal
Group 2 Group 5 Emulsion Subcutaneous
Group 3 Group 6 Emulsion Intraabdominal
-* 10 animals in each group
see text

cells were prepared by washing the cells 3 times in 0,9
per cent NaCl In a refrigerated centrifuge at 4,000 r.p.m.
for 10 minutes at 40 F. Stroma were prepared from the
washed erythrocytes by suspending the latter in distilled
water which was then run through a Sharpies Centrifuge to
collect the stroma.
Preparation of Emulsion .- Freund’s method49 of
preparing the emulsions was used. Two parts of the anti-
7gen were mixed with 1 part of Falba in a mortar, ' and the
mixture then combined with 2 parts of Bayol F containing
killed, dried M. tuberculosis Jamaica #22.
Injection Schedule .- Groups 1 and 4 received 1.5 ml
of antigen per week intraabdominally for the first 5 weeks
\
0.5 ml being given on 3 successive days of each week of
injection. Groups 2 and 5 received 1 dose of 2 ml of emul
sion subcutaneously, divided into 4 separate injections of
0.5 ml, 2 of which were injected into the left nuchal re-
gion and 2 simultaneously into the right. Groups 3 and 6
received 1 dose of 2 ml of emulsion divided into 2 injec-
tions of 1 ml each, which were introduced simultaneously
into the right and left sides of the intraabdominal cavity
•
See Table II for the total amouht of material injected.
Bleeding Schedule .- At each bleeding 5 ml of blood

TABLE V
Experiment II
Material Injected per Animal
Total amount Whole packed
Group material erythrocytes Stroma Falba Bayol F t.b.
injected
ml ml ml ml ml rnyrn
1 7.5 7.5 — — — —
2 and 3 2 oo•o — 0.4 0.8 0.2
4 7.5 — 7.5 — — —
5 and 6 2 00•o 0.4 0.8 0.2
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were obtained under aseptic conditions by cardiac puncture.
Samples were obtained at 0, 1, 2, 3, 4, 6, 8, 10, and 12
weeks from the beginning of the experiment. Since the in-
jections of Groups 1 and 4 were continued through the fifth
week, they were also bled at 5, 7, and 9 week intervals
•
The clotted blood remained overnight in the refrigerator
and the serum was then separated aseptically. The sera
were inactivated by heating to 56 C for 20 minutes, and
then kept without preservative in the refrigerator
Testing of Sera .- In Experiment I the guinea pigs’
and rabbits’ anti-rhesus sera were tested for the presence
of agglutinins. In Experiment II the guinea pigs’ anti-
human Rh sera were examined for agglutinins and blocking
antibodies
.
Agglutinins .- The basic method for testing for agglu-
tinins was as^ follows: Each serum was tested against 4
different red cell suspensions, 2 Rh -{-
,
1 CDe and 1 cDE
and 2 Rh negative (cde), keeping the source of erythrocytes
as constant as possible. A 2 per cent suspension was ob-
tained by adding whole blood to 0.9 per cent NaCl, centri-
•»
fuging, removing the supernatant, and resuspending the cells
to 2 per cent volume. One drop of serum was added to each
of four 75 x 9 mm blood grouping tubes. A drop of the
appropriate cell suspension was added to the tube, the mix-
T •
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ture shaken and incubated in a 37 C water bath for l/2 hour*
The tubes were then centrifuged at 500 r.p.m. for 30 seconds
and examined microscopically using a magnifying mirror*
Those that showed questionable or no clumping were examined
microscopically. Known positive and negative controls were
used each day. The positive serum control was human anti-D
serum and the negative control was normal guinea pig’s serum
which contained no agglutinins against human erythrocytes.
Three procedures were used in testing for agglutinins.
First the undiluted sera were tested for agglutinins to the
erythrocytes. One drop of the undiluted serum in this case
was added to each of the 4 test tubes. Positive sera were
diluted with 0.9 per cent NaCl in steps of 10 and tested
against the same cell suspensions to determine the strength
of agglutinin production, and to see whether Rh -/• and Rh
negative cells could be differentiated by dilution of the
serum. Undiluted sera that showed a minimum of 2 clum-
ping with Group 0 Rh
-/ erythrocytes were then absorbed
with packed human Group 0, type MN, Rh negative red cells
to test for the presence of specific Rh antibodies.
Blocking Antibodies .- After the erythrocytes to be
used for the test Rh v- and Rh negative suspensions had
been washed in 0.9 per cent NaCl 3 times, a 2 per cent
. . .
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suspension of the cells was made up in 30 per cent bovine
albumin. Each serum was tested against the 4 separate
cell suspensions, 2 of which were Rh and 2 Rh negative.
One drop of the serum to be tested was placed in each of
four 75 x 9 mm blood grouping tubes. One drop of the
appropriate cell suspension was added, the contents mixed,
and incubated in a 37 C water bath for 1 hour. The tubes
were then centrifuged at 500 r.p.m. for 1 minute and read
microscopically. Those that showed questionable or nega-
tive reactions were checked microscopically. The system
was checked with known human anti-D blocking serum.
Specific Rh Antibodies .- Absorptions v/ere carried
out in the same way whether for Rh agglutinins or blocking
antibodies. When absorbing for agglutinins, the sera v/ere
diluted 1:10 with 0.9 per cent NaCl (1:10 had been found
to be as suitable as undiluted or 1:5). When absorbing
for blocking antibodies, sera were used undiluted since
only a limited amount of bovine albumin was available.
In general, for each absorption 1 ml of serum was in con-
tact for 1/2 hour with 0.1 ml of packed human Group 0,
type MN, Rh negative erythrocytes which had been prepared
as described for the preparation of antigen. The suspen-
sion was then centrifuged, the supernatant removed, and
tested for either Rh agglutinins or blocking antibodies.
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as described above. If after 3 absorptions no Rh anti-
bodies had been obtained, absorption of that particular
antiserum was discontinued, for it 7/as found that a con-
tinuation of the procedure yielded no positive results.
Criteria for Evaluating Antisera .- In this study,
an adequate antiserum was defined as one that shov/s at
least a two step difference (Table IV) in strength of
reaction between Rh -/• and Rh negative cells (e.g., 2 -/•
with the 2 Rh -/ cell suspensions and — with the 2 Rh
negative cell suspensions). Those sera that showed a 1
or 1 l/2 step difference were called weak (e.g., 2 or
2 l/2 -/ with Rh -/, 1 v/ith Rh negative cells).
Results .-EXPERIMENT I.- In Experiment I the aggluti-
nins produced by the injection of rhesus erythrocytes in-
corporated in a water-in-oil emulsion into guinea pigs and
rabbits had disappeared by the time the sterile sera had
been in the refrigerator for a month and a half. Similar
observations were made with sera from guinea pigs and rab-
bits injected with rhesus stroma incorporated into an emul-
sion. Due to the disappearance of these agglutinins, no
information could be obtained on the strength or specificity
of the agglutinins or on the presence of blocking antibodies
Such an observation would indicate that the rhesus erythro-
cytes incorporated into a water-in-oil emulsion are unsatis-
factory as antigenic material for the production of Rh ag-
glutinins.

Results
.
- EXPERIMENT II.- As shown in Table III,
of the 3 groups of guinea pigs injected with packed human
Group 0, type MN, Rh erythrocytes (Group 1, 2, and 3),
adequate agglutinins were produced only in Group 1, in
which the plain antigen had been injected intraabdominally
•
Six of the 10 guinea pigs produced adequate agglutinins,
and 9 produced weak Rh agglutinins. One animal in Group
3, which received the antigen suspended in emulsion intra-
abdominally, produced weak antibodies. Group 2, injected
subcutaneously with the antigen-emulsion, produced no Rh
agglutinins. Of the 3 groups injected with stroma pre-
pared from the above Group 0, type MN, Rh -/• red cells
(Groups 4, 5, and 6), 1 animal in Group 4, which received
the plain stroma intraabdominally, produced adequate agglu-
tinins and 1 showed weak agglutinins. One animal in Group
6, which received the antigen-emulsion intraabdominally,
showed weak antibodies. Group 5, which received the anti-
gen-emulsion subcutaneously, behaved similarly to Group 6.
The time of appearance of specific Rh agglutinins
(see Table IV) differed markedly from the peak of general
agglutinin production. Six of the 7 adequate Rh antisera
(6 from Group 1, 1 from Group 4) were obtained from guinea
pigs 1 week, and one 2 weeks after the first injection of
antigen. Antisera obtained 3, 4, 6, 10, and 12 weeks after
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TABLE VI
Experiment II
Distribution of Adequate and Suggestive Rh Antisera
Group Antigen Route
Number of
Adequate
Rh Antisera
Guinea Pigs
Suggestive
Rh Antisera
Producing
No Rh
Antisera
1 packed
erythrocytes
i •a • 6 9 —
2 erythrocytes
in emulsion
S .C.-5H5- — — 10
3 erythrocytes
in emulsion
i.a. — 1 9
4 stroma i .a
.
1 1 8
5 stroma in
emulsion
s . c • — 1 9
6 stroma in
emulsion
i.a. — 1 9
# i.a. signifies intraabdominal injections
2HC- s.c. signifies subcutaneous injections
. .
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« .
• •
the injections were started showed no Rh agglutinins, (In-
jections of the antigen were continued through the fifth
week). Thirteen guinea pigs produced weak agglutinins;
1 after the first and second weeks of injection, 1 after
the first week and not subsequently, 10 two weeks after,
and 1 the fourth week after injections were started,
’.''/hen the sera, of the 6 experimental groups had been
tested for the presence of general anti-human Group 0, type
MN agglutinins, and for their strength, when present, by
titration in steps of 10, all 6 groups showed essentially
the same results. The titer was the same when tested
against the 4 separate suspensions of erythrocytes, 2 Rh -/•
(CDe and cDE) and 2 Rh negative (cde). Sera obtained 1 and
2 weeks after the first injection, which contained all 7
of the adequate and 13 of the 14 weak antisera, showed a
titer to the erythrocytes as a whole of undiluted to 1:1,000
the majority at 1:100, The peak of general agglutinin pro-
duction to the whole red cell or stroma occurred from the
fourth to the sixth week, primarily at the former. The peak
titer in no case went above 1:10,000, There was no rela-
tionship between titer and later demonstration of specific
Rh agglutinins upon absorption. The strength of differen-
tiation between Rh -/- and Rh negative erythrocytes by the
Rh agglutinins is indicated in Table IV,
.,
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TABLE VII
Experiment II
Summary of Strength of Rh Agglutinin Reactions of G-ninea
Pip; Antisera
Adequate Rh Agp:lutinins
Group
Guinea pig
Number
Week
Number Rh-/ Rh -/
Strength
Rh —
of Reactions
Rh —
1 1 1 2 2
3 1 2 2 _M-/-
6 2 2 2 _M-/ _M-/
7 1 2.5 2.5 11
—
2 2 2 _M-/-
8 1 2 2.5
10 1 2 2
4 31 1 2 2

TABLE VII Continued
Weak Rh Agglutinins
Guinea pig Week Strength of Reactions
Group Number Number Rh -/• Rh -A Rh — Rh —
1 1 2 1 1 — —
2 1 2 2 1 1
2 2 1
M
—
3 2 •/-ia-A 1
4 2 2 1
5 2 2 1 M
6 1 2 1 dk M
—
8 2 2,5 2 0 5 1 1
9 2 2.5 2 1 1
10 2 1 1
3 29 4 1 1.5 _M—
4 32 2 2 1.5
5 50 2 2 1 jAm~A -/•ZJA-A
6 51 2 2 2 i 1
4 + all cells are agglutinated into one clump that could
not be broken up upon gentle agitation
3 button at bottom of tube broken up into a few large
clumps
2 -/ button broken up into medium sized, well-defined clumps
1 button broken up into small clumps that were just
visible microscopically
zL questionable reaction
— no reaction
M-/- positive microscopically
M— negative microscopically
Half step reactions Indicate a strength between the two steps
> r.
Of the 2 technics used to determine the presence of
Rh agglutinins, namely, absorption of non-Rh agglutinins
with Group 0, type MN, Rh negative erythrocytes, and dilu-
tion of the sera, only the former method was effective.
In no instance did dilution of the serum in steps of 10
produce either adequate or weak agglutinins. No prezone
phenomenon was observed.
Blocking Antibodies .- The sera were also tested for
the presence of Rh blocking antibodies, that is, antibodies
that will differentiate between Rh -/• and Rh negative cells
when the erythrocytes are suspended in 30 per cent bovine
albumin, but not when suspended in saline. No Rh blocking
antibodies were obtained after absorption of the antisera
with Group 0, type MN, Rh negative red cells.
The unabsorbed sera from the first and second week
bleedings were titrated in steps of 10 against red cells
suspended in 30 per cent bovine albumin. There was no
difference in titer between the sera when tested against
cells suspended in 0.9 per cent NaCl and the albumin.
Since agglutinin production was so poor, and no blocking
antibodies were found, the more delicate Coombs 23 anti-
bodies were not Investigated.
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DISCUSSION
As indicated by the above experiment, the total
expression of antibody production to the Group 0, MN, Rh
positive erythrocytes as a whole was the same whether whole
cells or stroma were employed as the antigen, and whether
the antigen was suspended in saline or in a water-in-oil
emulsion. Incorporation of the Rh positive red cells into
the emulsion containing tubercle bacilli had an inhibiting
effect on Rh antibody production in the guinea pig. Only
whole red cells suspended in saline stimulated the produc-
tion of Rh agglutinins. Contrary to the observations re-
ported by Gallagher and Pillischer, no Rh agglutinins were
obtained in guinea pigs inoculated with the stroma of Rh
positive red cells prepared by Sharpies centrifugation.
At present no explanation can be offered for this dis-
crepancy.
Numerous interpretations may be offered to explain
the lack of response in the animals who received the Rh
positive red cells in emulsion. As indicated in Table II
the guinea pigs in the control group received a total of
t
7,5 ml of packed Rh positive erythrocytes. The groups in-
jected with the Rh positive cells in emulsion received a
total of 0.8 ml. At the time of peak Rh agglutinin pro-
*' I
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duction the second week after injections were started, the
animals in the control group had received 5 ml and the
emulsion groups 0.3 ml of the packed erythrocytes. Even
though at that time there was a 4-fold difference in the
amount of antigenic stimulus, it is hard to accept the
difference in Rh agglutinin production observed on a quan-
titative basis. Since all groups showed similar agglutinin
production to the human red cells as a whole, some Rh agglu-
tinins should have been found in the sera of guinea pigs
injected with the antigen in emulsion.
A second possibility may be that the weak Rh anti-
gens are masked more effectively by the stronger antigens
when the red cells are suspended in the emulsion. This
too seems unlikely, for if the antigen could get through
to the antibody-producing cells, multiple antibody forma-
tion would be likely to occur. Since both saline and emul-
sion groups showed a similar titer of antibody to the total
human erythrocyte, antigen must have penetrated to the cells
that form antibodies.
A third possibility is that the inhibiting effect of
l
the emulsion may be due to the chemical nature of the Rh
antigen. Incorporation of the antigen into an emulsion
may either destroy the Rh antigen or block it by either
*
physical or chemical combination. Since, as pointed out
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above, the antibody titer to the human Rh posit 3.ve red
cells as a whole is the same in both saline and emulsion
groups, the cells or their disintegration products must
have left the site of inoculation and come into contact
with the antibody-producing cells. In view of this fact,
the third possibility in our opinion seems to be the most
plausible explanation.
The method of choice for any further experiments
involving the use of guinea pigs for the production of
Rh or Hr agglutinins in response to the injection of red
cells would involve the inoculation of saline suspensions
of the antigen. So far, the intraperitoneal route has
been used exclusively for such injections. It would be
of interest to compare this route with intravenous inocu-
lations into the guinea pig.
The source of antigen for the production of Rh agglu-
tinins in animals has been either rhesus or human Rh posi-
tive red cells. The erythrocytes of each species are anti-
gens of great complexity. Only a small portion of the
total antigenic stimulus is produced by the desired Rh
antigen. For future work, a more concentrated or a pure
antigen would be desirable. Calvin, Evans, Behrendt and
Calvin12 and Carter17 have reported that a lipid fraction
extracted from Rh positive human erythrocytes contains a
.-
-
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,
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substance which inhibits human Rh antibodies. Carter
found that the fraction alone was nonantigenic in guinea
pigs. When combined with a n schlepper M (a potent antigen)
5 of 24 guinea pigs produced agglutinins to Rh positive
human erythro cytes • Whether they were Rh agglutinins
could not be determined from the report. Further experi-
ments would have to be undertaken to determine the anti-
genicity of this lipid using varying immunization pro-
cedures. Witebsky and Mohn isolated a substance from
the amniotic fluid of some infants. This substance inhi-
bited Rh antibodies, and when concentrated 10 times by
lyophilizing the material and resuspending it in l/lO
the volume of saline, is even more effective. No studies
have been published on the possible antigenicity of the
material.
Since animal anti-rhesus sera cannot differentiate
Rh positive from Rh negative infants, and since there is
evidence to indicate that the human D and rhesus antigens
are not identical, future antisera produced in animals
should be stimulated by human antigens.
No information has been published on any attempts
to produce Rh-Hr antisera other than anti-D agglutinins
in guinea pigs. Since sera for subtyping in particular
--
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.
are rare and the supply variable, it would seem that ex-
periments investigating the possibility of producing these
sera in animals should be undertaken. It would be very
important to completely subtype all cells employed for
both inoculation of the animals and absorption of the sera,
to eliminate all but the desired agglutinins*
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SUMMARY
1. Macacus rhesus erythrocytes gave rise to agglutinins
for human erythrocytes in 5 guinea pigs and 5 rabbits
injected subcutaneously with rhesus red cells in a
water-in-oil emulsion. Similar results were obtained
in the 5 guinea pigs and 5 rabbits that received rhesus
stroma suspended in the emulsion.
2. Upon standing in the refrigerator for a month and a
half after the initial testing, the anti-rhesus erythro-
cyte agglutinins had disappeared in the guinea pigs
’
and rabbi'ts T sera.
3. Human Group 0, type MN, Rh V- erythrocytes gave rise
to adequate Rh agglutinins in 6 of 10 guinea pigs in-
jected intraabdominally with a plain cell suspension.
Weak agglutinins were present in 9 of the 10 animals
of this group.
4. When Rh -/ erythrocytes were incorporated into a water-
in-oil emulsion with Falba, Bayol F and M. tuberculosis
Jamaica #22, not only was there no enhancement of Rh
antibody formation, but such agglutinin formation seemed
*
inhibited. Thus, the adjuvants used did not enhance
anti-Rh production but actually seemed to depress it.
;%
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5. When stroma were prepared by Sharpies centrifugation
of the above erythrocytes, the material was poorly
antigenic when tested by injection of the plain stroma.
Stroma incorporated into the above emulsion also pro-
duced no Rh agglutinins when injected into guinea pigs.
6. The peak of Rh agglutinin production was reached 1 to 2
weeks after weekly injections of the antigen were started.
The peak of agglutinin production to the whole Group 0,
type MN, Rh -/• red cell and stroma was reached the fourth
to sixth week after injection had been started.
7. Despite continued injection of the antigens, guinea pigs
producing Rh agglutinins no longer possessed these anti-
bodies after 2 weeks.
8. No Rh blocking antibodies were demonstrated.
9. Guinea pigs do not seem to produce anti-Rh agglutinins
comparable to good human sera.
10. Using part of Heidelberger 1 s method to prepare stroma
from rhesus, human, or horse erythrocytes, the original
cell volume and the final volume were the same.
11. Stroma prepared by Sharpies centrifugation are concen-
trated to 10 times the initial volume.
l.
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APPENDIX - TECHNICAL METHODS
I. Methods used with animal anti-Rh sera
Lands teiner and Wiener*^ 1941 - See P. 28
Immunization Procedure .- Washed red cells from 1 and
later 2 ml of whole blood of monkeys were injected into
the guinea pigs intraabdominally . Five days later the
animals were given a second injection and 1 week later
they were bled.
Testing for Agglutinins.- To test for the presence of
agglutinins 2 drops of serum and 1 drop of a 2 per cent
suspension were added to a small test tube, shaken, and
allowed to stand at room temperature for 30 to 60 minutes,
then read by direct examination of the sediment. After
an hour at room temperature, they were reread and the nega-
tive tests checked microscopically.
Landsteiner and Wiener7 ^ 1942 - See P. 29
Modified Immunization Method .- Red blood cells from
2 ml of rhesus blood were injected 5 times at 5 day inter-
vals. The animals were bled 1 week after the last injec-
tion. Satisfactory sera were pooled. Rh antisera were
produced by absorbing sera diluted 1:10 with saline with
l/lO volume of equal parts Group A and Group B red cells.

91
Davidson and Toharsky^0 - See P. 29
Immunization Procedure .- The rhesus red cells were
washed 3 times. The guinea pigs were injected intra-
abdominally with the cells from 1 ml of blood with 2 in-
jections at 5-day intervals. They also gave rabbits 7
daily intravenous injections of 0.1 ml of the suspension,
followed by a 3-week rest and then a second series of
injections. The guinea pigs and rabbits were bled 1 week
after the last injection of antigen.
Testing for Agglutinins .- In testing for Rh agglutinins
1-2 drops of serum and 1 drop of a 1 per cent red cell sus-
pension in saline were added to a small test tube, shaken,
incubated in a 37 C water bath for 1 hour, centrifuged for
1 minute at 500 r.p.m., then read, and checked microscopically.
104
Mclvor and Lucia * - See P. 33
Immunization Procedure .- In following the first schedule,
20 guinea pigs were injected intraabdominally with the red
cells from 2 ml of rhesus blood. Five days later a second
injection was given. Six weeks later 5 animals of the above
group were given a second series of similar injections. The
third schedule was tried on 16 guinea pigs. Three inocula-
tions, 5 days apart, were given. At this time injections
could not be continued for the animals were hypersensitive.
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Nine guinea pigs died soon after the third injection. The
fourth schedule consisted of 5 intraabdominal injections at
2-day intervals, starting with 1 ml and increasing 0,5 ml
with each injection. Bleedings were taken in the first 3
groups 7 days after the last injection of antigen. In the
last series blood was taken 2 days after the last injection.
To produce specific antisera, the serum was diluted 1:10
with saline, and immediately before use 0,05 ml of washed
Group A cells and 0,05 ml of washed Group B cells were
added to 1 ml of the diluted serum. The mixture remained
at room temperature for 1 hour. After absorption the serum
was further diluted 1:3 with saline. In testing for agglu-
tinins, 2 drops of serum and 1 drop of a 1.5 per cent cell
suspension were placed in a small test tube, incubated at
room temperature for 1 hour, then read.
nrj
Homburger - See P. 34
Immunization Procedure .- The guinea pigs received washed
cells from 1 ml of blood resuspended in saline, intraabdo-
minally. They were injected twice with a 5-day interval
between injections. The rabbits received 0.01 ml of citra-
ted cells suspended in 1 ml of saline, intravenously. They
were injected on 3 successive days, and 5 days later recei-
ved a second series of injections.
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Scherer
-
See P. 34
Immunization Procedure and Testing for Agglutinins
.
-
Nine animals were in the control group, 8 in the group in-
jected with ethylene disulfonate, 6 in the group injected
with pyrahenzamine, 8 in the group injected with sodium
salicylate, and 7 in the group injected with A and B "blood
group substances, making a total of 38 rabbits. Three
daily injections of 1 ml of 1:100 rhesus cells were given
intravenously. This was repeated 4 days later. Bleedings
were obtained before and at intervals during the experiment.
Sera were inactivated at 52-56 C for 30 minutes. To elimi-
nate agglutinins other than Hh, 1 ml of serum was absorbed
with 5 ml of packed Group 0, MN, Rh negative human red cells
for 1 hour at room temperature. The sera were tested against
Group 0, M CDe/cDE red cells suspended in saline, and sus-
pended in AB serum. Three drops of serum and 1 drop of a
2 per cent red cell suspension were placed in a small test
tube, incubated at 42 C for 1 hour, centrifuged at 500 r.p.m.
for 1-2 minutes, and read. The gradations of the reactions
were: 4 -/ if the reaction was visible macroscopically, 3,2,
1, and n
L
on the basis of the size of clumps visible micro-
scopically.
Carter'*'4 - See P. 36
Immunization Procedure.- The cells were washed and 6

intraabdominal injections given at 2-day intervals. The
first was 1 ml, the second 1.5 ml, and the rest 2 ml. The
animals were bled 2 days after the last injection. The sera
were pooled and absorbed with an equal volume of Group 0,
MU, Rh negative cells and inhibited with A and B substances.
Carter"^ - See P. 36
Immunization Procedure .- Six injections of 2 ml each
were given to 24 guinea pigs every other day. The animals
were bled 1 week after the last injection.
Gallagher and Pillischer56 - See P. 37
Immunization Procedure and Preparation of Anti sera .
-
The stroma were prepared by lysing the cells in distilled
water and passing the suspension through the Sharpies cen-
trifuge. The stroma were washed until free of hemoglobin.
The pale pink residue was repeatedly injected into guinea
pigs intraabdominally • One week after the last injection
the animals were bled and the sera inactivated at 56 C for
30 minutes. They were then absorbed with Rh negative red
cells.
Carter16 - See P. 37
Immunization Procedure .- The antigenicity of the lipid
material was tested as follows. Twenty-four guinea pigs and
2 rabbits were inoculated with a 10 per cent suspension of
.*
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the lipid material. Six injections of 2 ml each were made
on alternate days into the guinea pigs intraabdominally and
into the rabbits intravenously. Bleedings were made 1 week
after the last injection.
II. Technical Methods
Landsteiner and Wiener^® - See P. 40
Original Method of Testing for Agglutinins .- Two drops
of the test serum or serum dilution made up with saline were
mixed with 1 drop of 2 per cent fresh red cells suspended
in saline in a small test tube. The tests were allowed to
remain at room temperature for 1 hour and then read by
direct examination of the sediment. "Negatively reacting
bloods then show a circular deposit with a smooth edge,
while positive bloods show a wrinkled sediment with a ser-
rated border or show a granular deposit." The tubes were
then shaken and read again after 2 hours at room temperature.
The sediment was again examined macros copically and the sus-
pension examined microscopically.
Diamond and Abel son - See P. 43
Slide Test .- 0.2 ml of fresh oxalated Rh negative, Rh^
and Rh
-2 Group 0 whole blood or 40-50 per cent cell sus-
pensions are placed on a glass slide. 0.1 ml of the serum
to be tested is added to each blood. The mixture is tilted
and read in 1-3 minutes. The reaction occurs a little more
rapidly at 37 C, but can be carried out at room temperature.
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Simmons See P. 44123
Slide Tes t,- The Rous-Turner mixture used to suspend
the red cells consists of 2 solutions. Solution 1 is made
up of 16 ml of 5.4 per cent glucose in distilled water,
solution 2, 6.6 ml of 3.8 per cent Na citrate in distilled
water. Solutions 1 and 2 are autoclaved at 110 C for 15
minutes, then mixed together. A drop of a 5 per cent sus-
pension of the patient’s cells is mixed with the first, a
drop of known Rh positive suspension to the second, and a
drop of known Rh negative cells to the third of 3 drops of
potent anti-D serum placed in separate rectangles drawn on
a glass slide. The specimens are mixed and incubated for
30 minutes at 37 C, then gently rocked and readings made.
Witebsky, Rubin and Blum^°^ - See P. 47
Method of Testing the Enhancing Property of Normal Sera
on Anti-Rh Sera .- Decreasing amounts of the anti-Rh serum
in a total volume of 0.1 ml were mixed with 0.1 ml of a 3
per cent suspension of Group 0, Rh positive red cells.
Saline, adult sera, cord sera, and premature sera were
tested for their capacity to cause agglutination by the
blocking antibodies. They were used both as diluent for
the blocking sera and suspension medium for the red cells.
The tests were incubated for 1 hour at 37 C, shaken slightly
centrifuged at moderate speed for 2 minutes, and read.
IH
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Diamond and Denton^
Albumin Blocking Test .- Two testing technics were recom-
mended: a. Cell suspensions of Croup 0 Rh^_ Rhg and Rh
negative red cells washed 3 times were made up to 2 per cent
in 20 per cent bovine albumin. One drop of undiluted serum
was placed in each of 3 small tests tubes and 2 drops of the
appropriate cell suspension was added. The mixture was sha-
ken, incubated in a 37 C water bath for 5-10 — 30 minutes,
centrifuged for 1 minute at 500 r.p.m., and read macrosco-
pically. Negative reactions were confirmed microscopically,
b. In running routine tests, if a test for agglutinins was
negative, the material was centrifuged, the supernate re-
moved and replaced by 2 drops of 20 per cent bovine albumin.
The tube was shaken, allowed to remain at room temperature
for 5 minutes, centrifuged, and read. If blocking anti-
bodies were present, the cells would then clump.
Fisk and McGee^S _ See P. 53
C-elatin Blocking Test .- The gelatin solution was pre-
pared by dissolving 10 g of gelatin and 1 g of di-sodium
acid phosphate in 90 ml of distilled water. This was auto-
claved for 15 minutes at 121 C. After sterilization, the pH
was about 6.7. The solution could be kept at room tempera-
ture and heated before use. 1:10,000 merthiolate was added
to avoid contamination.
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The qualitative test - 1 drop of undiluted plasma or
serum, 1 drop of 10 per cent gelatin solution, and 1 drop
of oxalated blood of known Rh type were placed in a test
tube. This was incubated at 37 C for 5 minutes and dilu-
ted with 2 ml of saline before reading. Fresh blood speci-
mens must be used.
The quantitative test - the test was set up as for an
agglutinin titration. Dilutions of the serum and the 2 per
cent cell suspension were prepared in saline. 0.2 ml of
the serum dilution and 1 drop of the 2 per cent cell sus-
pension were added to the appropriate tube. After 30 minu-
tes at 37 C the reactions were read. The tubes were then
centrifuged, the saline removed, and replaced by 0.2 ml of
a 3 per cent gelatin solution. An alternate method v/as to
eliminate the removal of saline and add 0.1 ml of the 10
per cent gelatin solution to each tube. The material was
shaken and reincubated at 37 C for 30 minutes. Before
reading 0.2 ml of saline was added to each tube. This did
not interfere with the reaction and eliminated pseudo-
reactions •
Coombs 25 - See P. 53
Direct Test for Blocking Antibodies .- The red cells were
freed from serum as completely as possible by washing 3 times
in large volumes of saline. 2-5 per cent cell suspensions
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were prepared in saline. Either 1 of 2 methods which gave
parallel results may he U3ed. If the test was carried out
on a tile, 1 drop of the rabbit’s anti-globulin serum was
added to 1 drop of the cell suspension. The tile was rocked.
If positive, the reaction occurred at room temperature in
5-10 minutes. The test may be carried out in the same way
in test tubes.
Coombs 2 ^ - See P. 54
Indirect Test .- Two drops of the serum to be tested and
2 drops of a 2 per cent washed red cell suspension of the
appropriate type were added to small test tubes. After
incubation at 37 C for 30 minutes, the sediment was ex-
amined microscopically. Two points in the technic were of
particular importance. One was the use of a 2 per cent
cell suspension. If too light the cells would not agglu-
tinate. If too heavy, the reaction was more difficult to
read. The second point was that 3 washings were necessary
to remove all human globulin except that which was specifi-
cally absorbed onto the red cell surface. It was important
to carry out the first part of the test at 37 C, but the
second part showed equally good results at 37 C, 22 C, and
8 C.
Simmons - See P.
Methods of Preparing Sera Used as Antigens .- One method
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was the alcoholic precipitation of globulin, which was
then dissolved in saline for use. The second method was
Proom f 3 method^0 using alum-precipitated serum,
Haberman and Hill^ - See P, 57
Elution of Rh Antibodies from Sensitized Erythrocytes •
-
The red cells of cord blood were washed 3 times in cold
saline. After the last washing 1 ml of fresh saline was
added to 0.25 ml of packed cells. The cells were resuspen-
ded and placed in a 56 C water bath for 5 minutes. The
suspension was immediately centrifuged at 3,000 r.p.m. for
5 minutes, keeping the temperature at 56 C. The saline
eluate was removed and recentrifuged to assure removal of
all cells. The supernate was then tested for the presence
of Rh agglutinins in the usual way by mixing 1 drop of the
eluate with 1 drop of 2 per cent suspension of red cells
in saline.
Chown20 - See P. 58
Capillary Tube Method .- Whole blood or blood diluted up
to 1:4 could be used. Capillary tubing with a 0.4 mm bore
was cut into 0.9 mm lengths and sterilized. One end was
dipped into an agglutinating serum and a column of about
2 mm allowed to enter. The same end was then dipped into
the blood without any air bubbles intervening. The tube
was inverted e, couple of times to permit mixing. One end
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was placed in a lump of plasticine at a 45° angle from the
horizontal. The tube was incubated at 37 C for 15 minutes
and read against a white background.
,.
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ABSTRACT
The Use of Adjuvants In the Production of Rh Antisera In
Animals
The purpose of this investigation was to determine
whether the avidity and strength of Rh antisera produced
in animals could he increased by incorporating the anti-
gen into a water-in-oil emulsion*
The discovery of a new antigen present in human
erythrocytes was indicated in 1940 by 3 lines of inves-
tigation* Landsteiner and Wiener reported an agglutinin
produced in rabbits injected with Macacus rhesus erythro-
cytes* Identical agglutinins were observed in 2 cases
of intra-group transfusion reactions by Wiener and Peters
and in a woman who gave birth to an erythroblast otic in-
fant by Levine and Katzin*
The need for Rh antisera has taken its place next
to that for anti-A and anti-B blood grouping sera.* The
clinical situations where it is necessary to know the Rh
types are in transfusions, pregnancies, and infants with
evidence of erythroblastosis* Prognosis for future preg-
nancies of women with erythroblastotic infants may be
made by determining the homo- or heterozygosity of the

father . Rh typing is also useful in medico-legal prob-
lems and in familial and anthropological studies.
Most of the antisera used at present are obtained
from mothers of erythroblastctic infants, persons v/ho
have received multiple transfusions of blood incompatible
for the Rh-Hr antigens and male volunteers. The most
potent sera are obtained from the first group where there
is a constant antigenic stimulus over a long period of time
Numerous workers have attempted to produce usable
Rh antisera in rabbits and guinea pigs by injecting them
« /
with rhesus erythrocytes, human erythrocytes, or stroma
or extracts prepared from the latter. The general con-
clusion arising from such studies is that the Rh factors
are poor antigens when administered in the usual way.
Increasing use has been made of adjuvants to enhance
antigenic stimulus. When the antigen is suspended in the
water phase of a water-in-oil emulsion, it is released
more slowly over a longer period of time. This method of
immunization has been successful with a number of sub-
stances, including such weak antigens as alcoholic ex-
tract of brain, histaminazo protein and ragweed pollen.
Since the most potent Rh antisera in humans are pro-
duced in mothers of erythroblastotic infants, and since
-*
.
.
•.
-
'
"
.
-
~
.
"
t
the adjuvant method of immunization also exposes the re-
active organism to the antigenic stimulus over a long
interval, this method was applied in the present inves-
tigation.
Two experiments were carried out. In both the ad-
juvants used were Falba, Bayol F, and tubercle bacilli.
The antigen was suspended in the water phase of a water-
in-oil emulsion. Rhesus erythrocytes and rhesus stroma
in emulsion were injected intraabdominally into guinea
pigs and rabbits in the first experiment. Human Group 0,
MIT, Rh -/ erythrocytes and stroma in saline were injected
intraabdominally, and in emulsion intraabdominally and
subcutaneously into guinea pigs in the second experiment.
* * * *
Sera were obtained by cardiac puncture at 0, 1, 2, 3, 4,
6, 8, 10, and 12 week intervals after initiation of the
experiment. In Experiment I they were examined for ag-
glutinins by titrating in steps of 10 using two 2 per
cent suspensions of Rh -/ red cells and 2 of Rh negative
erythrocytes. Sera from Experiment II were examined for
agglutinins in the same way, absorbed with Group 0, MIT,
Rh negative erythrocytes, and the absorbed sera tested
for anti-Rh antibodies with the same four 2 per cent
cell suspensions. When tested for agglutinins and block-
ing antibodies, the cells were suspended in 0.9 per cent

4saline and in 30 per cent bovine albumin respectively.
In this study, an adequate Rh antiserum was defined as
one that showed at least a 2 step difference in strength
of reaction between Rh -/• and Rh negative cells. These
sera that showed a 1 or 1 l/2 step difference were called
weak.
Agglutinins produced in guinea pigs and rabbits to
rhesus erythrocytes and stroma suspended in emulsion dis-
appeared after standing in the refrigerator for a month
and a half after the original titrations. This seemed to
indicate that Rh agglutinins, if present, were too weak
to be useful.
Of the 3 groups of guinea pigs injected with human
Group 0, MN, Rh -/• erythrocytes, adequate agglutinins were
produced only in Group 1 in which plain antigen had been
injected intraabdominally . Six of the 10 guinea pigs pro-
duced adequate agglutinins, and 9 produced suggestive anti-
bodies, Group 2, injected subcutaneously with the antigen-
emulsion, produced no Rh agglutinins. One animal in Group
3, which received the antigen in emulsion intraabdominally,
produced suggestive antibodies.
Of the 3 groups injected with stroma prepared from
the above red cells, 1 animal in Group 4, which received
the plain stroma intraabdominally, produced adequate agglu-
..
.
.
.
tinins and 1 showed suggestive agglutinins. One animal
in Group 5, which received the antigen-emulsion subcuta-
'
"
neously, showed suggestive antibodies. Group 6, which
received the emulsion intraabdominally
,
behaved similarly
to Group 5.
The time of appearance of specific Rh agglutinins
differed markedly from the peak of general agglutinin pro-
duction. Six of the 7 adequate Rh antisera were obtained
from guinea pigs 1 week and one 2 weeks after the first
injection of antigen. Antisera obtained 4, 6, 8, 10, and
12 weeks after injections were started showed no Rh agglu-
tinins. Injections of the antigen were continued through
the fifth week. Of the 13 guinea pigs producing sugges-
tive Rh agglutinins, 1 produced the antibodies after the
first and second week of injection, 1 after the first and
not subsequently, 10 two weeks after, and 1 the fourth
week after injections were started*
When sera of the 6 experimental groups had been
tested for the presence of general anti-human Group 0, I,IN
agglutinins, and for their strength, when present, by ti-
tration in steps of 10, all 6 groups showed essentially
the same results. The titer was the same when tested
against the 4 separate suspensions of erythrocytes, 2 Rh
I
and 2 Rh negative. Sera obtained 1 and 2 weeks after the
.-
t
first injection, which contained all 7 of the adequate
and 13 of the 14 suggestive Rh antisera, shov/ed a titer
to the erythrocytes as a whole of undiluted to 1:1,000,
the majority at 1:100. The peak of general agglutinin
production to the whole cell or stroma occurred from
the fourth to sixth week, primarily at the former. The
peak titer in no case exceeded 1:10,000. There was no
relationship between titer and later demonstration of
specific Rh agglutinins upon absorption.
Of the technics used to determine the presence of
Rh agglutinins, namely, absorption of non-Rh agglutinins
with Group 0, MN, Rh negative erythrocytes, and dilution
of the sera, only the former method was effective. In
no instance did dilution of the serum in steps of 10 pro-
duce either adequate or weak agglutinins. No prezone
phenomena was observed.
The sera were also tested for the presence of Rh
blocking antibodies. None were observed after absorption
of the antisera with Group 0, MN, Rh negative red cells.
The unabsorbed sera from the first and second week
bleedings were titrated in steps of 10 against red cells
suspended in 30 per cent bovine albumin. There was no
difference in titer between sera when tested against cells
suspended in 0.9 per cent NaCl and the albumin.

Since agglutinin production was so poor and no
blocking antibodies were observed, the more delicate
Coombs antibodies were not investigated.
,
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